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ABSTRACT
The Na/K-ATPase (NKA) was identified in 1957 by Dr. Jens C. Skou. It belongs to the
P-type ATPase family, which can actively transport ions across cell membranes by using the
energy from adenosine triphosphate (ATP) hydrolysis. During the second half of the 20th
century, the molecular mechanism of the NKA catalytic cycle was clarified, and the isoform
diversity of NKA in different species and organs was identified. The active ion transport through
NKA generates cell membrane ion gradients and the electric potential. Hence, the enzymatic
function of NKA is critical for cell viability as well as multiple physiological processes including
muscle contraction, renal sodium reabsorption, and nerve impulse transmission. Inhibition of
NKA-mediated ion transport by cardiotonic steroids (CTS), which have long been used in the
clinical treatment of heart failure, improves cardiac inotropy. Moreover, CTS at low
concentrations were found to induce signal transduction through NKA, revealing its receptor
signaling function. In addition to its role as an ion pump, the NKA α1 isoform forms a signal
receptor complex with the non-receptor tyrosine kinase Src and the scaffolding protein caveolin1 (Cav1). The gain of the caveolin binding motif (CBM) in the α1 NKA is required for the nonion pumping function of NKA and the early stages of organogenesis in mice and C. elegans.
Considering the reported importance of NKA non-ion-pumping function in metabolic
disorders, we further tested whether the loss of this CBM altered adiposity in mice and impaired
adipogenesis in a human induced pluripotent stem cell (iPSC) model. At the age of 6-months,
NKA CBM mutant (mCBM) heterozygous mice exhibit altered adiposity and reduced white
adipose tissue (WAT) mass. The histology of mCBM WAT indicated tissue fibrosis and chronic
inflammation, which may contribute to adipose tissue metabolic dysfunction. To further
understand the molecular mechanism, we used an mCBM human iPSC model and a

xi

differentiation protocol to mimic the adipogenesis process in vitro. These studies indicated that
the loss of CBM function in NKA α1 in human iPSC induces extracellular matrix (ECM) fibrotic
remodeling. The ECM remodeling does not block the commitment of stem cells into adipocytes.
However, it results in increased oxidative stress, insulin resistance, chronic inflammation, and
eventually metabolic dysfunction during adipogenesis.
Thus, we characterized a novel role of the non-ion pumping NKA and its interaction with
Cav1 in the regulation of stem cell differentiation and adipogenesis. This provides novel insight
into the complex dynamic of regulation of caveolar structure and function in the adipocyte and
could be of therapeutic relevance in the management of fat-related disorders ranging from
genetic lipodystrophies to metabolic syndromes.

xii

CHAPTER 1
INTRODUCTION
The theory of active ion transport through the cell membrane was proposed in the 1940s.
In 1957, Dr. Jens C. Skou first identified an ATPase enzyme that was activated in the presence of
both Na+ and K+ ions and worked as an ion pump (Skou, 1957). Dr. Skou later named it Na/KATPase (NKA). The NKA belongs to the P-type ATPase family. Approximately 23% of the total
ATP consumed in humans at rest is utilized by NKA. It plays a significant role in animal
physiology by helping maintain resting potential, active transport, and cellular volume (Skou &
Esmann, 1992). The NKA is a transmembrane protein with three subunits: α, β, and γ. The
catalytic α subunit contains three domains, which allows active transport of three Na+ and two K+
through the conformational changes of NKA in one pump cycle (Lingrel & Kuntzweiler, 1994;
Lingrel, Van Huysse, O'Brien, Jewell-Motz, Askew, et al., 1994; Morth et al., 2011). They are
four isoforms of the NKA α subunit in mammalian species, and their sequences are highly
homologous. The distribution of the α1 isoform is ubiquitous, and other isoforms are organspecific (Blanco & Mercer, 1998). The α isoforms show different affinities for ions, substrate,
and ligands (cardiotonic steroids, CTS) in different species and organs (Pressley, Duran, &
Pierre, 2005), but the physiological relevance of this isoform diversity remains incompletely
understood for the most part.
Studies in the 21st century have shown that NKA is not only an ion pump but also a signal
transducer. By coupling with the scaffolding protein caveolin-1 (Cav1) and the protein tyrosine
kinase Src, a pool of caveolae-localized NKA α1 can form a signaling complex that responds to
low concentration of CTS by inducing signal transduction (Z. Xie, 2003; Z. Xie & Cai, 2003).
The caveolin binding motif (CBM) on the N-terminus of NKA was identified as the NKA-Cav1
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binding site and is conserved across species (Cai et al., 2008; H. Wang et al., 2004). The loss-offunction mutant NKA α1 CBM (mCBM) does not affect the enzymatic function of NKA, but
disrupts NKA/Cav1/Src signalosome, perturbs human cell stemness markers, and is
embryonically lethal in the mouse (Cai et al., 2008; X. Wang et al., 2020).
Early studies have shown that two isoforms of the NKA α subunit are expressed in
adipocytes: α1 and α2 (Brodsky, 1990; Resh, 1982a, 1982b). It has also been known for some
time that insulin stimulates ion transport through adipocyte NKA and that the two α isoforms
have different sensitivity to insulin (Lytton, 1985; Lytton, Lin, & Guidotti, 1985; Resh, 1982a).
More recently, we have learned that NKA α1 and α2 have different signaling properties (J. Xie et
al., 2015). Moreover, there is genetic evidence that the α1 isoform-specific signaling function of
NKA exhibits a distinct role in energy metabolism (Kutz et al., 2021) and pharmacological
support for an effect in obesity and related complications (Sodhi et al., 2015; Sodhi et al., 2017).
These features point to an important and specific physiological role of the caveolar α1 signaling
in adipose physiology that has remained unexplored.
This led us to ask the question: is adipogenesis regulated by the non-ion pumping
properties of α1 NKA? Using a genetic approach in the mCBM model, an NKA α1 signalingnull mutant model that does not affect the enzymatic function of NKA, we conducted a
mechanistic investigation of the importance of the non-ion pumping scaffolding function of
NKA in the regulation of adipogenesis in human induced pluripotent stem cells (iPSC).
I.

Historical Background
In the 1930s, it was generally recognized that the cell membrane is impermeable to Na+.

To explain the different electrochemical potential of Na+ between inside and outside the cell, R.
Dean first raised a hypothesis that there must be an ion pumping mechanism on the cell
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membrane, which can pump Na+ out and pump K+ in (Dean, R. B. 1941). The concept of active
transport developed during the 1940s and 1950s. By the research of short-circuit current in frog
skin, Johnsen, et al. showed that the current is carried by active transport of Na+. The influx of
extracellular K+ is essential for the efflux of Na+ (Koefoed-Johnsen, Ussing, & Zerahn, 1952). A
link between an active transport of Na+ and K+ was suggested (Skou & Esmann, 1992).
The finding that metabolic inhibitors impaired the active transport of Na+ indicated that
energy-rich triphosphate esters are the substrates of the active transport. In red blood cells, ATP
was found to be able to support the influx of K+. Furthermore, ATP was identified as the only
substrate which can support active transport, as it could not be replaced by other triphosphates
such as GTP, ITP, or UTP (Clarkson & Maizels, 1954; Gardos, 1954; Hoffman, 1962). The
Na+/K+ stoichiometry was later determined in experiments in red blood cells and purified
reconstituted systems. It was shown that 3 moles of Na+ and 2 moles of K+ are transported when
1.16 moles of ATP were hydrolyzed (C. B. Jorgensen, Levi, & Zerahn, 1954; A. K. Sen & Post,
1964; Skou & Esmann, 1992). In 1953, Schatzmann observed that CTS inhibit the active
transport of Na+ and K+, which is specific to the Na/K pump. CTS had been used for the therapy
of heart failure for over one hundred years, but the mechanism was still unrevealed (Schatzmann,
1953). The active transport of K+ and Na+ also generates an electric potential across the
membrane, which is positive on the outside. The pumping of Na+ and K+ only adds a few
millivolts to the membrane potential in normal cells with a high permeability to Cl-, (Kernan,
1962; Thomas, 1969). However, this may be critical to the pulse transmission of synapses in the
central nervous system (Skou & Esmann, 1992).
In 1957, Skou first identified a novel membrane-bound protein with ATPase properties
from the crab nervous giant axon sheath (Skou, 1957). His finding suggested that this ATPase
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was involved in the active transport of Na+ and K+. However, in the 1950s and 1960s, the models
of the cell membrane structure were incomplete. For a transport system across the membrane, a
protein must have access to both sides of the membrane. Thereby, without the recognition that
membrane proteins are spanning the bilayer of lipids, it was difficult to reconcile the structure of
an ion-pumping ATPase. The suitable model was introduced in 1972 as the fluid mosaic
membrane model. (Singer & Nicolson, 1972; Skou & Esmann, 1992). Dr. Skou received the
Nobel Prize in chemistry in 1997 for the first discovery of the ion-transporting enzyme Na/KATPase.
II.

Structure of NKA
The NKA is a complex of two polypeptide subunits: α and β. The α-subunit contains the

binding sites for cations and ATP. It couples ATP hydrolysis with the active transport of ions.
The β subunit is essential for the assembly of a fully functional protein. The γ subunit,
discovered later, is associated with the function of NKA in a tissue-specific manner (Lingrel &
Kuntzweiler, 1994; Skou & Esmann, 1992).
The α-subunit contains about 1012 amino acids forming 10 transmembrane helices (M110). Both the N-terminus and C-terminus are on the intracellular side. The sequences of αsubunit from several species and different tissues are identical with more than 92% homology
(Blanco & Mercer, 1998; Levenson, 1994). The membrane-spanning segments of the α subunit
have an α-helical structure. The large intracellular loop between M4 and M5 is predominantly a
β-sheet structure. The α-subunit has three functional domains: the actuator (A) domain includes
the N-terminus and the second cytosolic domain (CD2) connected to M2 and M3, the
phosphorylation (P) domain resides close to the membrane and is highly conserved, and the
nucleotide-binding (N) domain and the C-terminus contains the ATP binding site (Blanco &
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Mercer, 1998; Lingrel & Kuntzweiler, 1994; Lingrel, Van Huysse, O'Brien, Jewell-Motz,
Askew, et al., 1994; Lingrel, Van Huysse, O'Brien, Jewell-Motz, & Schultheis, 1994; Skou &
Esmann, 1992). In 3D orientation, transmembrane helices M1–M6 form the core of the
membrane transport domain and hold the main ion-binding sites. The C-terminal helices M7–
M10 bind to the core through interaction sites within M6-M7. Upon Na+ binding, the conserved
aspartic acid residue of the P domain is auto-phosphorylated using ATP bound to the N domain.
Subsequently, K+ binding stimulates the dephosphorylation of the P domain, which is catalyzed
by glutamic acid in the conserved TGE motif in the A domain (Fig. 1B), (Morth et al., 2011).
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Figure 1. Structural and functional domains in NKA.
A. Schematic diagram of α and β subunits of NKA, adapted from Blanco G. et al. (Blanco &
Mercer, 1998). B. Crystal structure and domain organization of NKA, adapted from Morth JP, et
al. (Morth et al., 2011)
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Four α isoforms are found in human tissues. They are expressed in a tissue-specific
manner and regulated during ontogeny and diseases (Pressley et al., 2005). The α1 isoform is
found in all cells, the α2 isoform is found in muscle and adipose tissue, and the α3 isoform is
mainly found in the nervous tissue together with α1 and α2. The α4 isoform is in the testis and
regulates sperm motility (Pressley et al., 2005). The four isoforms differ in their amino acid
composition and sequence, with major differences observed in the N-terminal part (P. L.
Jorgensen & Andersen, 1988). The four isoforms show different sensitivity towards cation
concentration, ATP concentration, and CTS in different species and tissue (Table 1) (Blanco &
Mercer, 1998; Lingrel & Kuntzweiler, 1994; Lingrel, Van Huysse, O'Brien, Jewell-Motz,
Askew, et al., 1994; Lingrel, Van Huysse, O'Brien, Jewell-Motz, & Schultheis, 1994; Pressley et
al., 2005).

Species and tissue
Rodent brain

Major differences
Affinity for CTS of NKA α2 and α3 is higher than α1

Reference
(Sweadner, 1985)
(Munzer, Daly,
NKA α3 displays a higher affinity for extracellular K+
Rat enzyme expressed in
Jewell-Motz,
and lower affinity for intracellular Na+ relative to α1 and
HeLa cells
Lingrel, & Blostein,
α2
1994)
Insulin stimulates NKA α1 due to a small increase in
(McGill & Guidotti,
Rat adipocyte
Na+ affinity and stimulates the α2 isoforms due to
1991)
increased Na+ affinity and an increase in the Vmax.
(Daly, Lane, &
Rat enzyme expressed in
Blostein, 1996;
The α2 isoform displays a faster rate of occluded K+
HeLa cells and monkey
Petrosian, Carr,
release
kidney cells
Guerrero, &
Pressley, 1998)
Mammalian skeletal
α2 isoform responds to insulin by translocation from an
(Hundal et al., 1992)
muscle
intracellular pool to the plasmalemma
Table 1. Isoform-specific differences in NKA α-subunits.
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The β-subunit contains about 300 amino acids (Shull, Schwartz, & Lingrel, 1985). There
is one transmembrane segment near the N-terminus, and the C-terminus is located on the
extracellular side (Fig. 1A) (Blanco & Mercer, 1998). The β-subunit is heavily glycosylated on
the extracellular side, with a mass of sugar of about 10kD (Chow & Forte, 1995). There are three
β-subunit isoforms. The sequences of β-subunit reveal a low homology between the isoforms
(Blanco & Mercer, 1998). The β1 is the primary form in the mammalian kidney. The β2 was
mainly isolated from the brain and it has been shown to play a role in cell-cell interaction. The
β3 was later isolated from Xenopus (Sweadner, 1991).
Besides the protein subunits, negatively charged phospholipids are necessary for full
NKA enzyme activity (Ottolenghi, 1979). The bilayer lipids act as a solvent for the protein and
thus have a structural effect on the protein to perform the necessary conformation changes. A
protective effect of negatively charged lipids has also been observed (Cornelius & Skou, 1988).
It is generally accepted that the ratio between the two polypeptide chains is 1:1. The αβ-unit is
the minimal functional unit of the enzyme, and higher oligomers have also been described
(Maunsbach, Skriver, & Hebert, 1991). The higher oligomers are more stable than the αβstructure. This implies that the enzyme has several different modes of organization within the
membrane (Y. Hayashi, Mimura, Matsui, & Takagi, 1989).
III.

Catalytic Cycle of NKA
In the presence of Mg2+, the hydrolysis of ATP by NKA is activated by a combined effect

of Na+ on the cytosolic side and K+ on the extracellular side (Robinson, 1969, 1970). In contrast,
the cytosolic K+ and extracellular Na+ act as inhibitors of the pumping cycle. At the extracellular
sites, several monovalent cations can replace extracellular K+ for action, but with decreasing
affinity in the order: K+>Rb+>NH4+>Cs+>Li+>Na+. At the cytosolic sites, Li+ is the only cation
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that can replace Na+ for action (Skou, 1988; Skou & Esmann, 1992). The ATP hydrolysis
turnover number is about 10,000 per minute at 37 degrees Celsius. (Pollack, Tate, & Cook,
1981b)
NKA has two major conformations as the E1 and E2 forms. The catalytic cycle was first
proposed by Albers and Post (Fig. 2) (Albers, Koval, & Siegel, 1968; Post, Kume, Tobin, Orcutt,
& Sen, 1969). In the absence of Na+ and K+, the NKA is in the E2 form. Two K+ binds to E2
(E2K2) and turns E2 into a new form with K+ occluded (E2’K2). In the E2’K2 form, the K+
binding is very stable (Karlish, Yates, & Glynn, 1976). Na+ binding to the E2 form with the
affinity K0.5=5 mM turns the enzyme into the E1 form (Karlish et al., 1976). Then, three Na+
bind the E1 form (E1Na3). ATP triggers the phosphorylation of E1Na3. In the presence of Mg2+,
the phosphate from ATP is transferred to Asp369 in the α subunit (E1PNa3) (Ohtsubo, Noguchi,
Takeda, Morohashi, & Kawamura, 1990). The occlusion of Na+ is the rate-limiting step in the
phosphorylation reaction. In the following steps, Na+ is released to the extracellular side and the
E1PNa3 is converted to E2P form, which has a high affinity for K+ and low affinity for Na+. One
of the three Na+ is released, and then the phospho-enzyme with two occluded Na+ undergoes the
conformational change to the E2P form. E2P has a high affinity for extracellular K+, it
dephosphorylates rapidly upon K+ binding. The dephosphorylation then leads to an occlusion of
K+ (E2’K2). ATP increases the rate of K+ release to the intracellular side, it also increases the
rate of transition to E1Na3MgATP in the presence of Na+ (Lingrel & Kuntzweiler, 1994;
Lingrel, Van Huysse, O'Brien, Jewell-Motz, Askew, et al., 1994; Morth et al., 2011; Skou &
Esmann, 1992).
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Figure 2. Albers-Post mechanism.
During a catalytic cycle, NKA undergoes conformational changes as E2-E1-E1P-E2P-E2
and actively transports three Na+ and two K+ across the cell membrane. Gadsby, et al.
(Gadsby, Bezanilla, Rakowski, De Weer, & Holmgren, 2012)
IV.

Ligands of NKA
Cardiotonic steroids (CTS), a group of steroid compounds, were introduced into clinical

practice over 1000 years ago (K. K. Chen & Kovarikova, 1967). The scientific study of CTS
began with William Withering's clinical observation of foxglove in the 1780s (Whayne, 2018).
CTS were identified as specific inhibitors of the NKA (Schatzmann, 1953; Skou, 1957). In the
presence of Mg2+, CTS can bind to the extracellular loops of the α subunit of NKA and inhibit
10

ion-pumping (Burns, Nicholas, & Price, 1996; Croyle, Woo, & Lingrel, 1997; Vasilets, Takeda,
Kawamura, & Schwarz, 1998). CTS differ in their affinity for NKA. For a given CTS, the
inhibitory effect on NKA varies for different species and different tissues (Blanco, Melton,
Sanchez, & Mercer, 1999; O. V. Fedorova, Kolodkin, Agalakova, Lakatta, & Bagrov, 2001; O.
V. Fedorova, Lakatta, & Bagrov, 2000; Geering, 2005; Mobasheri et al., 2000). The most widely
used CTS, ouabain, originates from a plant and has a K0.5 of 10-4 – 10-2 mM for NKA enzyme
from most tissues (Bagrov, Shapiro, & Fedorova, 2009; Skou & Esmann, 1992). CTS includes
two subfamilies, the cardenolides with a five-membered lactone ring, and the bufadienolides
with a six-membered lactone ring (Fig. 3).
The NKA is the receptor for the inotropic effect of CTS in the heart. The inhibition of
NKA increases intracellular Na+, leading to a reduction of the sodium-calcium exchanger (NCX)
activity and an enhanced Ca2+ influx. The increased intracellular Ca2+ leads to increased
contractility by the heart muscle (Baker, Blaustein, Hodgkin, & Steinhardt, 1969; Blaustein &
Hamlyn, 2020; Reuter et al., 2002).
The presence of an endogenous ouabain-like ligand in animals had been postulated since
the 1950s (Blaustein, 2018). In 1961, the role of endogenous CTS in the pathogenesis of
hypertension was implicated in a series of studies (De Wardener, Mills, Clapham, & Hayter,
1961; Gruber, Whitaker, & Buckalew, 1980; Hamlyn et al., 1982; Kojima, Yoshihara, & Ogata,
1982; Overbeck, Pamnani, Akera, Brody, & Haddy, 1976). In 1991, endogenous ouabain (EO)
purified from human plasma was identified by mass spectrometry (Hamlyn et al., 1991; Ludens
et al., 1991). The mammalian EO is identical to the plant-derived ouabain (Hamlyn et al., 1991;
Schneider et al., 1998), and proposed to be synthesized in the adrenal medulla (Komiyama et al.,
2001). Endogenous bufadienolides were also identified in mammalian species and human plasma
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(Hilton et al., 1996; Lichtstein, Gati, & Ovadia, 1993; Sich, Kirch, Tepel, Zidek, & Schoner,
1996). Unlike ouabain that can produce weak vasoconstriction, the bufadienolide
marinobufagenin produces rapid and strong vasoconstriction (Bagrov, Roukoyatkina, Pinaev,
Dmitrieva, & Fedorova, 1995). The endogenous bufadienolides are synthesized by
adrenocortical cells using cholesterol precursor, but unlike ouabain, this does not require
cholesterol side-chain cleavage (Dmitrieva et al., 2000; Dmitrieva, Lalli, & Doris, 2005)
The plasma levels of EO in healthy humans is about 0.2 nM (Manunta et al., 1999; J. G.
Wang et al., 2003), which is much lower than the IC50 of ATPase activity. Hence, a signaling
effect of EO is thought to contribute to its role in physiological processes. EO was found to
modulate cell Ca2+ signaling and peripheral vascular resistance via α2 NKA and NCX (Zhang et
al., 2005). Moreover, the renal sodium handling function and EO related cardiac hypertrophy
was linked to a signaling function of α1 NKA through tyrosine kinase Src and Mitogen-activated
protein kinase (MAPK) pathway (Bagrov et al., 2009; Briones et al., 2006; Ferrandi et al., 2004;
Hauptman & Kelly, 1999; Rossoni et al., 2002). Our recent study has shown that different CTS
have biased effects on NKA-mediated signaling, which could explain some of the paradoxical
effects of CTS. This NKA-mediated signal transduction will be discussed in detail in the next
section.
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Figure 3. Molecular Structure of CTS.
Cardenolides ouabain and digoxin, and bufadienolides marinobufagenin and proscillaridin A are
shown. Adapted from Bagrov, et al. (Bagrov et al., 2009)
V.

Signaling NKA

Overview of the Signaling NKA
In addition to the regulation of NKA enzymatic activity, CTS has also been reported to
play an important role in the regulation of cell proliferation and differentiation since the 1970s.
Ouabain at a very low concentration (nM range) was found to regulate gene expression and the
mitogen-induced differentiation and proliferation of mouse lymphoblasts (Cuff & Lichtman,
1975; Kaplan, 1978; Pollack, Tate, & Cook, 1981a). Given the IC50 of ouabain for NKA in
mouse lymphoblasts, the effect of nM concentrations of ouabain on lymphoblast proliferation
and differentiation is unlikely due to the substantial inhibition of transmembrane ion transport
via NKA, suggesting that additional mechanisms may be involved in CTS-induced regulation of
cell proliferation and differentiation.
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In the 1990s, a series of studies initiated by Xie and his colleagues revealed that CTS
could induce protein tyrosine phosphorylation and several signaling pathways in a cell type- and
tissue type-dependent manner (Haas, Askari, & Xie, 2000; Haas, Wang, Tian, & Xie, 2002; L.
Huang, Li, & Xie, 1997; Kometiani et al., 1998; Z. Xie et al., 1999). This has now largely been
confirmed by studies from other laboratories around the world (Bielawski, Winnicka, &
Bielawska, 2006; Dmitrieva & Doris, 2003; Ferrandi et al., 2004; Golden & Martin, 2006;
Kulikov, Eva, Kirch, Boldyrev, & Scheiner-Bobis, 2007; J. Li, Zelenin, Aperia, & Aizman,
2006; M. Li, Wang, & Guan, 2007; Lopez-Lazaro et al., 2005; Mijatovic et al., 2007; RamirezOrtega et al., 2006; Trevisi, Visentin, Cusinato, Pighin, & Luciani, 2004). These new findings
suggest possible signaling functions of NKA in addition to its traditional ion-pumping function.
These studies have suggested that there is a pool of caveolae localized non-pumping NKA that
functions as a potential receptor (J. X. Xie, Li, & Xie, 2013; Z. Xie & Cai, 2003). They further
suggested that a non-ion-pumping pool of α1 NKA is concentrated in caveolae rafts, where it
interacts with scaffolding protein Cav1 and tyrosine kinase Src to form an NKA/Src receptor
complex. Src is then maintained inactive. Ouabain binding stabilizes the conformation of NKA.
This binding further induces the formation of multiple signaling modules by changing the
interaction of NKA with neighboring membrane proteins. This eventually results in the
activation of Src, transactivation of the downstream mitogen-activated protein kinase (MAPK)
pathway through Epidermal Growth Factor Receptor (EGFR), and reactive oxygen species
(ROS) generation. (J. X. Xie et al., 2013; Z. Xie & Cai, 2003). This signaling cascade regulates
multiple intracellular processes in cell physiology (Fig. 4).
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Figure 4. Schematic representation cellular processes regulated by Na/K ATPase/Src
signalosome mediated signal transduction.
The signal transduction and heterogeneity of the NKA signalosome could explain the
mechanism of low concentration CTS-mediated regulation of cell proliferation and vascular
activity. Changes in NKA expression dictate the signaling effects of ouabain on cell proliferation
(Tian, Li, et al., 2009). Moreover, the signaling function of NKA was found to be essential for
ouabain’s effect on cardiac myocytes (Tian, Gong, & Xie, 2001; Tian, Liu, Garlid, Shapiro, &
Xie, 2003). Ouabain at 10 to 100 nM was sufficient to increase collagen production in mouse or
rat cardiac fibroblasts (El-Okdi et al., 2008; Quintas et al., 2010), which is much lower than the
NKA IC50 (about 100 μM) in mouse/rat fibroblasts and cannot be explained by inhibition of its
ion-pumping property.
After the discovery of NKA-mediated signal transduction, follow-up studies by Wang et
al., Yuan et al., and Chen et al. showed that NKA has a significant scaffolding function. NKA is
capable of interacting with the scaffolding protein Cav1 (Y. Chen et al., 2008; H. Wang et al.,
2004; Yuan et al., 2005). Such ability allows NKA to signal from caveolae. The NKA-caveolin
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interaction is also critical for Cav1 membrane trafficking (Cai et al., 2008) (see next section for
details).
The signaling function of NKA is isoform-specific. Using mRNA interference, Xie and
his colleagues were able to knock down 90% of the endogenous NKA α subunit and express
exogenous α isoforms of rodent NKA in pig kidney epithelial cell LLC-PK1 (Liang, Cai, Tian,
Qu, & Xie, 2006). The CTS-induced Src activation and tyrosine phosphorylation is NKA α1
dependent (Liang et al., 2006; Liang et al., 2007). In a pig epithelial cell model with 90%
endogenous NKA knockdown, expressing either rodent α1 or α2 NKA in the cells show no
difference in NKA enzymatic function. However, the α2 rescued cells lack Src-dependent signal
transduction. No difference in enzymatic kinetics was observed. Ouabain stimulated Src/ERK
cascade in the α1 but not the α2 rescued cells (J. Xie et al., 2015). In the α3 rescued cells, CTS
induced ERK activation through Src-independent pathways involving PI3K and PKC, which is
distinct from that of cells expressing NKA α1 or α2 (Madan et al., 2017).
The NKA α1-mediated regulation of Src kinase activity is based on two Src-interacting
domains. A peptide of 20 amino acids (Serine 415 to Glutamine 434) (NaKtide) derived from the
nucleotide-binding domain of α1 NKA was shown to be able to bind and inhibit the kinase
domain of Src (Z. Li et al., 2009). Expression of either A420P or A425P mutant α1 in
endogenous NKA α subunit knockdown cells fully restored the α1 content and consequently the
ATPase capacity of cells. However, the A420P and A425P mutants were incapable of interacting
and regulating cellular Src (Lai et al., 2013). The second cytosolic (CD2) domain of the NKA α1
subunit can interact with the SH2 domain of Src, which recruits Src to specific signaling
complexes. The Y260A mutation on NKA α1 CD2 abolished Src-dependent signal transduction
in LLC-PK1 cells (Banerjee, Duan, & Xie, 2015). Moreover, by introducing the key residues of
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NaKtide sequence and SH2 binding sequence into the NKA α2 sequence, the mutant α2 gained
α1-like signaling function, including Src interaction and CTS-induced Src/ERK activation (Yu et
al., 2018).
Caveolin and the Conserved NKA Caveolin Binding Motif
The cell membrane surface pit-like depression termed caveolae were first identified in the
mouse gall bladder epithelium in the mid-1950s (Yamada, 1955). However, the functions of
caveolae were not unveiled until the discovery of the first caveolae-associated structural protein,
Cav1, in the 1990s (Kurzchalia & Parton, 1999; Rothberg et al., 1992). Caveolae are flaskshaped vesicular invaginations, consisting of approximately 140-150 Cav1 molecules (Parton &
Simons, 2007). The amount of caveolae structures varies remarkably in different cells. For
example, caveolae structures are nearly undetectable in lymphocytes (Fra, Williamson, Simons,
& Parton, 1995), but highly abundant in fibroblasts and adipocytes (Parton, 2003). Caveolae
participate in numerous cellular processes, including endocytosis, transcytosis, and signal
transduction (Kurzchalia & Parton, 1999; Sargiacomo et al., 1995; Williams & Lisanti, 2005).
Multiple signaling components are localized and concentrated within the cell membrane caveolar
structure (Fujimoto, Miyawaki, & Mikoshiba, 1995; Lockwich et al., 2000; Z. L. Tang, Scherer,
& Lisanti, 1994; H. Wang et al., 2004). Taken together, the membrane caveolar network serves
as a microdomain for compartmentalization of signal transduction, which facilitates signal
transduction events in a space-specific manner.
The caveolin proteins are the major components of caveolae (Williams & Lisanti, 2005).
Since the discovery of Cav1, a total of three caveolin genes have been found in mammals:
CAV1, CAV2, and CAV3, which encode four caveolin proteins: Cav1α, Cav1β, caveolin-2
(Cav2), and caveolin-3 (Cav3). Cav1 and Cav2 are co-expressed in most types of cells other than
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myocytes, where Cav3 is the major isoform. Some types of cells, such as cardiomyocytes,
express all three caveolins (Robenek, Weissen-Plenz, & Severs, 2008). Caveolin interacts with
itself to form homo-oligomers via its cytoplasmic N-terminal domain interaction, and functions
as a scaffolding protein to concentrate and organize signaling molecules within the caveolar
structure (Sargiacomo et al., 1995). The N-terminal caveolin scaffolding domain (CSD, residues
82-101) of caveolin can interact with proteins’ caveolin binding motif (CBM), whereas the
intramembrane domain (residues 102-134) forms a unique α-helical hairpin that inserts into the
cell membrane, thereby pinning signaling proteins within the membrane caveolae. (Aoki,
Thomas, Decaffmeyer, Brasseur, & Epand, 2010; Ostermeyer, Ramcharan, Zeng, Lublin, &
Brown, 2004; Parton, Hanzal-Bayer, & Hancock, 2006; Razani, Woodman, & Lisanti, 2002)
The functions of caveolae and caveolin proteins in cell biology have been studied
extensively (Parton, 2003; Parton & del Pozo, 2013; Parton & Simons, 2007). Abnormalities of
caveolins have been found in various human diseases. Mutations in the CAV3 gene were found
to be associated with muscular dystrophy (Galbiati, Razani, & Lisanti, 2001). On the other hand,
mutations in the CAV1 gene are associated with lipodystrophy (Garg & Agarwal, 2008; Garg et
al., 2015; Schrauwen et al., 2015). This indicates the significant role of caveolin functions in the
development of muscle and adipose tissue. Moreover, Cav1 expression is upregulated in patients
with obesity-associated type 2 diabetes mellitus (Catalan et al., 2008), suggesting that Cav1 and
related signaling events may be involved in adipose tissue metabolism and obesity development.
To further investigate the physiological relevance of caveolins, Dr. Lisanti and his
colleagues have generated mice deficient in genes that encode caveolins. Additional research
groups, using standard homologous recombination, have generated mice deficient in the Cav1
gene. As Cav1 is the major isoform in most types of cells, Cav1 knockout is sufficient to
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eliminate the caveolae structure in non-muscle cells (Razani et al., 2001; Zhao et al., 2002). The
Cav1 knockout mouse displays defects in lipid metabolism and adipocyte function, resulting in
resistance to high fat diet-induced obesity (Razani, Combs, et al., 2002). In addition, the
Cav1/Cav3 double knockout mouse lacks both muscle and non-muscle caveolae, which leads to
the development of severe cardiomyopathy at the age of two months, probably due to
hypertrophy, disorganization, and myocytes degeneration in the heart (Park et al., 2002).
The normal receptor function of NKA requires its localization in membrane caveolae,
which provides the membrane microdomain that further allows protein-protein interaction (Z.
Xie & Cai, 2003). Earlier studies in the 2000s have indicated that α1 NKA co-localizes with Src
in caveolae, and that disruption of caveolae formation by either Cav1 knockdown or cholesterol
depletion abolishes CTS-induced Src activation and downstream signal transduction (Cai et al.,
2008; J. Liu et al., 2005; H. Wang et al., 2004). Hence, the scaffolding function of Cav1 is
critical in the formation of the NKA signalosome.
The interaction of caveolin and other proteins commonly occurs between the caveolin
scaffolding domain (CSD) on caveolin and the aromatic-rich CBM on its partner proteins. The
CBM is identified as the consensus sequence: ΦXXΦXXXXΦ, ΦXΦXXXXΦ, or
ΦXΦXXXXΦXXΦ, where Φ represents an aromatic amino acid residue and X represents any
amino acid. (Anderson, 1998; Schlegel & Lisanti, 2001; Smart, Ying, Donzell, & Anderson,
1996). Two highly conserved potential CBM in the mammalian α1 NKA have been identified:
FCROLFGGF at the N terminus and WWFCAFPY at the C-terminus (Fig. 5).
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Figure 5. Schematic of α1 NKA conserved caveolin binding motifs.
The N-terminus CBM is on the intracellular side and conserved across different species. Wang et
al. 2004. (H. Wang et al., 2004)
The direct interaction of NKA and Cav1 is supported by several lines of evidence. First,
these two proteins can be co-immunoprecipitated from cell or tissue lysates. Further, GST-pull
down assays shows a direct interaction between Cav1 through the Cav-scaffolding domain and α1
NKA (H. Wang et al., 2004). Additionally, sucrose gradient fractionation studies indicated that α1
NKA and Src are highly enriched in caveolar fractions (H. Wang et al., 2004). Moreover,
Fluorescence Resonance Energy Transfer (FRET) analyses showed that α1 NKA and Cav1 are colocalized and interact. This interaction is abolished by either knockdown of α1 NKA or mutation
of the N-terminal CBM (F97A and F100A) on α1 NKA (Cai et al., 2008).
The interaction between α1 NKA and Cav1 is regulated by Src-dependent cellular signal
transduction. Indeed, ouabain-induced Src activation facilitates Cav1 binding to the α1 NKA. In
20

addition, ouabain stimulates Y14 phosphorylation of Cav1 and increases Cav1 mobility via α1
NKA-associated Src (H. Wang et al., 2004). The trafficking of Cav1 from the Golgi apparatus to
the plasma membrane also appears to be regulated by α1 NKA. Knockdown of α1 NKA in LLCPK1 cells resulted in the redistribution of Cav1 from the plasma membrane to cytosolic vesicles.
This redistribution is rescued by both wild-type and pump-null exogenous α1 NKA, but not the Nterminal CBM mutant (F97A and F100A) α1 NKA (Cai et al., 2008). This suggests that the nonion pumping property of α1 NKA is critical for the regulation of Cav1 trafficking and membrane
distribution. Interestingly, α1 NKA not only regulates Cav1 behavior through CBM-mediated
interaction but also regulates Cav1 mobility via Y-14 phosphorylation by regulation of Src activity.
This is consistent with the established role of Src in the control of Cav1 trafficking (GottliebAbraham et al., 2013; Labrecque et al., 2004).
Given that the C-terminal CBM resides on the extracellular side of NKA (Morth et al.,
2007), the N-terminal CBM is thought to be key to NKA/Cav1 interaction. To further characterize
the biological property of the CBM on α1 NKA, Wang X et al. introduced a CBM F97A and
F100A double mutant rat α1 NKA (mCBM) in the α1 NKA knockdown LLC-PK1 cell. This
mutant disrupted the NKA/Src signalosome, eliminated CTS-induced signal transduction, without
affecting the ion pumping activity of NKA (X. Wang et al., 2020). The mCBM cells showed
dramatically reduced cell proliferation capacity (X. Wang et al., 2020).
Furthermore, to study the non-ion pumping function of NKA in animal physiology, the α1
NKA CBM F97A and F100A double mutant knock-in mouse line was generated using the strategy
developed in the Lingrel laboratory (Dostanic, Schultz Jel, Lorenz, & Lingrel, 2004). Unlike the
viable mouse lines with the knockout of Cav1, IP3R, or Src (M. Hayashi et al., 1999; Razani et al.,
2001; Soriano, Montgomery, Geske, & Bradley, 1991), the homozygous CBM mutation of α1
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NKA in mouse is embryonic lethal (X. Wang et al., 2020). The mCBM does not block blastocyst
formation and gastrulation but arrests the organogenesis at embryonic day 8.0 and onward,
including the development of the brain, heart, limbs, and spinal cord. The overall size of embryos
at embryonic day 9.5 was ~20% reduced in mCBM heterozygous and ~75% reduced in mCBM
homozygous in comparison to the wild type. No homozygous embryos were found after embryonic
day 12.5 (X. Wang et al., 2020). The CBM on NKA is evolutionarily conserved. The consensus
sequence of FCxxxFGGF on NKA is present in all multicellular organisms within the animal
kingdom (X. Wang et al., 2020). Similar to the mouse, mCBM on NKA of C. elegans also resulted
in the arrest of organogenesis (X. Wang et al., 2020). Taken together, these data demonstrated the
critical role of NKA CBM and the non-ion pumping functions of NKA in organogenesis during
embryonic development, and this property of NKA is conserved among different species.
To further assess the molecular mechanism and human relevance of NKA CBM mediated
regulation of tissue development, the same CBM mutation was introduced on NKA α1 in human
induced pluripotent stem cells (iPSCs) using CRISPR-Cas9 gene editing (X. Wang et al., 2020).
The expression of mCBM abolished the colony formation of human iPSCs, which was
accompanied by a dramatic reduction in the expression of stemness marker genes (X. Wang et al.,
2020). This suggested that the differentiation status of iPSCs was altered by mCBM.
Mechanistically, the canonical Wnt/β-catenin signaling pathway, which is critical in animal
organogenesis (Chenn, 2008; Nusse, 2005), is found to be altered in mCBM cells. First, the cellular
distribution of -catenin in mCBM cells is shifted from the plasma membrane to cytosolic vesicles,
suggesting the disassembly of the Wnt/-catenin signaling complex. Secondly, TOPFlash
luciferase activity assays show that mCBM reduced Wnt pathway activity by ~90%, indicating
that the mCBM cells failed to respond to Wnt ligands or Wnt pathway agonist stimulation.
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Moreover, Wnt3a failed to induce the expression of its downstream marker genes in mCBM cells
(X. Wang et al., 2020). At last, global changes of gene expression in the Wnt signaling pathway
indicated by RNA-seq and pathway analysis confirmed the defect of Wnt/β-catenin signaling in
homozygous mCBM embryos. This was further confirmed by the downregulation of neurogenesis
essential genes in homozygous mCBM embryos, which is regulated by Wnt/β-catenin signaling
during embryonic development. Consistently, developmental defects in neural closure are
observed in histological sections of homozygous embryos at embryonic day 9.5. (X. Wang et al.,
2020).
Altogether, these suggest that the mCBM on NKA is critical in the regulation of stem cell
differentiation and mouse embryonic development, possibly due to both the scaffolding function
of NKA/Cav1 interaction and signal transduction mediated by NKA signalosome. The role of
NKA CBM in stem cell differentiation in the context of adipogenesis, which is the focus of this
research, is further considered in the following chapters.
VI.

Classic and Novel roles of NKA in the Adipose Tissue: the case for a role in
adipogenesis

Overview of Adipogenesis
The adipose tissue is derived from the mesoderm during embryonic development. The
differentiation of stem cells into adipocytes is termed adipogenesis. The process of adipogenesis
consists of multiple phases, which are characterized by chronological changes in the expression of
early, intermediate, and late marker genes and lipid accumulation (Fig. 6). (Cristancho & Lazar,
2011; Gregoire, Smas, & Sul, 1998; Lee, Schmidt, Lai, & Ge, 2019).
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Figure 6. Overview of the stages in adipocyte differentiation.
In the commitment stage, the pluripotent stem cells differentiate into mesenchymal precursors,
preadipocytes, and eventually into adipocytes. This cell fate determination is regulated by
transcriptional signal networks, including multiple Wnt signaling pathways. The maturation
stage is initiated by the expression of PPARγ and its downstream target genes encoding
functional proteins that are critical in lipid metabolism. The mature adipocyte is characterized by
large lipid droplets in the cytoplasm. Adapted from Gregoire. et al. 1998 (Gregoire et al., 1998).
From Mesenchymal Stem Cell (MSC) to Preadipocyte: role of Wnt Signaling and
Extracellular Matrix
The commitment of mesenchymal stem cells (MSCs) to preadipocytes results in the loss
of the potential to differentiate into other types of cells such as chondrocytes, myocytes, and
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osteoblasts (Gregoire et al., 1998). This stem cell lineage determination is regulated by crosstalk
between signaling cascades, including the Wnt signaling pathway and TGF-β signaling, as well
as modifiers of extracellular matrix (ECM) structure (Cristancho & Lazar, 2011; Lee et al.,
2019). For example, the canonical Wnt signaling through Wnt10b promotes osteogenesis
and inhibits adipogenesis in MSCs (Steger et al., 2010). Non-canonical Wnt ligands signal
through β-catenin-independent pathways. The non-canonical Wnt5B also facilitates osteogenesis
and inhibits adipogenesis (Fretz et al., 2010), whereas another non-canonical Wnt5A promotes
adipogenesis by inhibiting canonical Wnt (Seo et al., 2009). TGF-β expression inhibits in
vitro adipogenesis through activation of Smad-3 and increasing synthesis of ECM components
(Hiraike et al., 2017; Zamani & Brown, 2011). In contrast, several TGF-β superfamily bone
morphogenetic proteins (BMPs) were reported to promote adipogenesis through the p38 kinase
pathway (H. Huang et al., 2009).
The composition and stiffness of the ECM also regulate lineage commitment of
mesenchymal stem cells. Low stiffness of ECM promotes adipogenesis in vitro (Engler, Sen,
Sweeney, & Discher, 2006; Rowlands, George, & Cooper-White, 2008; Winer, Janmey,
McCormick, & Funaki, 2009). In contrast, a stiffer ECM with a higher concentration of collagen
I attenuate adipogenesis (Chun et al., 2006). ECM stiffness causes persistent tissue tension,
which leads to enhanced actin and myosin fiber formation and cell stretching, eventually shifting
the cell fate toward MSCs (Akimoto et al., 2005; Jakkaraju, Zhe, Pan, Choudhury, & Schuger,
2005). Exposure to mechanical strain activates Wnt/β-catenin and inhibits adipogenesis in MSCs
(B. Sen et al., 2008). Matrix metalloproteinases (MMPs) can cleave ECM components and
thereby regulate the stiffness and composition of ECM (Visse & Nagase, 2003). MMP14 is
essential for adipose tissue development (Chun et al., 2006). Complete inhibition of MMP
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activity by inhibitors of MMPs impairs adipose tissue development in vivo (Chavey et al., 2003;
Croissandeau, Chretien, & Mbikay, 2002; Lijnen et al., 2002; Maquoi, Munaut, Colige, Collen,
& Lijnen, 2002). Cell-cell contact and cell shape also influence adipogenesis via regulation of
RHO GTPase–RHO-associated kinase (ROCK) signaling (Dike & Farmer, 1988; Kilian,
Bugarija, Lahn, & Mrksich, 2010; McBeath, Pirone, Nelson, Bhadriraju, & Chen, 2004). ROCK
signaling inhibits adipogenesis. Confluent or rounded human MSC have inactive ROCK due to
inhibition of the dissociation of RHO-GDP, thereby promoting adipogenesis. Conversely, RHOGTP in spread cells has activated ROCK, which inhibits adipogenesis and promotes
myogenesis/osteogenesis through anti-adipogenic Wnts (Dike & Farmer, 1988; Kilian et al.,
2010; McBeath et al., 2004). Moreover, p190-B RHOGAP, a factor that controls RHO activity,
has also been found to be critical in MSC lineage commitment. Mice lacking p190-B RHOGAP
show decreased adiposity with decreased adipogenic capacity and increased myogenic capacity
of mouse embryonic fibroblasts (MEFs) (Sordella, Jiang, Chen, Curto, & Settleman, 2003).
From Preadipocyte to Adipocyte: major role of PPARγ and C/EBPα
Following MSC lineage commitment, the preadipocyte is further committed to adipocyte
during adipogenesis. Growth arrest is required for adipocyte commitment. Two transcription
factors — CCAAT enhancer binding protein (C/EBP-α) and proliferator-activated receptor-γ
(PPAR-γ) — appear to be involved in this process. Both are activated by adipogenic stimuli
(Cristancho & Lazar, 2011; Gregoire et al., 1998). C/EBP proteins are the early markers for
adipocyte commitment. C/EBPβ expression is extensively increased by the induction of
adipogenic stimuli such as cAMP agonists (Yeh, Cao, Classon, & McKnight, 1995). C/EBPδ
expression is also induced rapidly by glucocorticoids upon the addition of adipogenic stimuli
(Yeh et al., 1995). Subsequently, the expression of C/EBPα and PPARγ is further induced by
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C/EBPβ (Cristancho & Lazar, 2011; Q. Q. Tang, Zhang, & Daniel Lane, 2004). PPARγ is the
dominant regulator of adipogenesis. It belongs to the type II nuclear hormone receptor family
and forms heterodimers with the retinoid X receptors (RXR) (Gregoire et al., 1998; Juge-Aubry
et al., 1995). The PPARs are activated by numerous ligands, including the thiazolidinedione
(TZD) class of antidiabetic drugs (Gregoire et al., 1998). PPARγ is the most adipose-specific
member of the PPARs, and the expression of PPAR-γ is sufficient to induce adipogenesis in
fibroblast cell lines, demonstrating its significant role in the regulation of adipogenesis (Hu,
Tontonoz, & Spiegelman, 1995; Tontonoz, Hu, & Spiegelman, 1995).
Upon expression of PPARγ, the adipocyte becomes mature with increasing lipid
accumulation. During the adipocyte maturation, PPARγ and C/EBPα induce the expression of
multiple adipocyte genes, including genes encoding insulin signaling pathway components,
lipogenic enzymes, fatty-acid-binding proteins, and adipose cytokines (Gregoire et al., 1998).
Moreover, PPARγ and C/EBPα regulate each other in a positive feedback circuit to maintain the
gene expression in mature adipocyte, whereas the expression of C/EBPβ and C/EBPδ is reduced
(Cristancho & Lazar, 2011; Wu et al., 1999).
Glucose Handling and Lipogenesis in the Mature Adipocyte
During the maturation of adipocytes, glucose uptake is mediated by the insulin-sensitive
glucose transporter (GLUT4) in response to insulin stimulation. The glucose is then converted
into pyruvate via glycolysis, converted into acetyl CoA, and enters the mitochondrial TCA cycle
(Sethi & Vidal-Puig, 2007). Additionally, free fatty acids (FFA) are generated from triglycerides
hydrolysis by the lipoprotein lipase (LPL) on the adipocyte cell membrane, and then transported
across the membrane (Peterson et al., 1990). The FFA then binds to adipocyte protein 2 (aP2)
and converts into acetyl CoA to enter the mitochondrial TCA cycle (Sethi & Vidal-Puig, 2007).
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The citrate produced by the TCA cycle is utilized to synthesize FFA via fatty acid synthase
(FASN). The FFA are then subjected to de novo synthesis of triglyceride, and the triglycerides
are stored in the lipid droplets of mature adipocytes (Sethi & Vidal-Puig, 2007).
In the development of obesity, excess lipid accumulation leads to adipocyte hypertrophy,
which is characterized by enlarged cell size, disorganized cortical actin, and impaired GLUT4
translocation (Choe, Huh, Hwang, Kim, & Kim, 2016). The hypertrophic remodeling of the
obese adipose tissue results in local adipose tissue hypoxia, which further activates the hypoxiainducible factor (HIF) 1α and disturbs the homeostasis of adipose tissue macrophage, increases
the secretion of inflammatory cytokines like MCP-1, TNFα, and IL-6 (Choe et al., 2016).
Eventually, this remodeling accelerates adipose tissue fibrosis, chronic inflammation, and results
in insulin resistance in the adipose tissue (Choe et al., 2016; Sun, Tordjman, Clement, & Scherer,
2013).

The NKA of the Adipose Tissue
The adipose tissue specializes in storing energy as fat, generating heat, and secreting
cytokines. The adipocyte is the primary cell type in adipose tissue, which is derived from adipose
tissue fibroblast. A series of studies of NKA in adipose tissue were published in the 1980s. The
number of Na pump sites, ATP turn over, and efficiency was initially quantitated in rat adipose
cells (Table. 2.)(Resh, 1982b). Following the discovery of the new NKA α-isoform in the brain
(Sweadner, 1979), two different NKA α-isoforms were identified in the rat adipose tissue as α
(25%) and α+ (75%), which were later termed as α1 and α2 (Lytton et al., 1985).
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Table 2. NKA properties in rat adipose tissue. Resh MD (Resh, 1982b).

A series of studies in adipocyte differentiation of cultured mouse fibroblast 3T3-L1 cells
indicated that an NKA isoform-switch from α1 to α2 occurs during adipocyte differentiation
(Resh, 1982b; Russo, Manuli, Ismail-Beigi, Sweadner, & Edelman, 1990). Either increase of
intracellular sodium or stimulation by insulin activates NKA in adipocytes. (Brodsky, 1990;
Lytton, 1985). Although the sodium affinity and insulin sensitivity of NKA α1 and α2 isoforms
are different, isoform-specific modulation of their ion-pumping function is an unlikely
explanation for the requirement of both isoforms in adipocytes. Indeed, it has been estimated that
only 12% of the maximal total NKA activity is required in living cells (Brodsky, 1990; Resh,
1982b). The isoform-specific signaling function of NKA α1 and α2 (J. Xie et al., 2015) may
imply a regulatory role of NKA in signaling events in adipose tissue that has not been explored
yet.
Novel Functions of NKA: importance in the Adipose Tissue
Although not explicitly tested to date, some of the isoform-specific properties of the
signaling NKA, combined with recent pharmacological investigations, support a significant role
in adipocyte differentiation and specific functions. For example, a metabolic switch from
oxidative respiration to aerobic glycolysis has been observed in α2-expressing cells without α1specific signaling function, suggesting a role for α1 NKA signaling in energy metabolism
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(Banerjee et al., 2018; Kutz et al., 2021). Consistent with a physiological role, the α1 NKA
signaling is also critical for the development and metabolism of the skeletal muscle, one of the
few organs expressing both α1 and α2 NKA (Kutz et al., 2021; Kutz et al., 2018).
Pharmacological approaches in vivo and in vitro also support the existence of an
underappreciated role of NKA signaling in adipose tissue. Indeed, in a series of studies by Dr.
Sodhi and her colleagues, the NKA α1-mimetic peptide pNaKtide mediated the inhibition of
adipogenesis in vitro, prevented high-fat diet-induced obesity, and reduced multiple obesityrelated complications in mice via normalization of NKA α1/Src and subsequent attenuation of
reactive oxidative species (ROS) generation (J. Liu et al., 2016; Pratt et al., 2019; Sodhi et al.,
2015; Sodhi et al., 2018; Sodhi et al., 2017; Sodhi et al., 2020). Mechanistically, ROS are
chemical modifiers of the NKA that can regulate and amplify the signal transduction mediated
by NKA (Z. Xie, 2003; Z. Xie & Cai, 2003; Yan et al., 2013).
Finally, the NKA scaffolding function and its effect on caveolar integrity may also
influence adipose physiology. Indeed, the membrane caveolar structure is associated with
adipocyte lipid trafficking (Pilch & Liu, 2011; Pilch, Meshulam, Ding, & Liu, 2011). Besides the
lipid metabolic defects in Cav1 null mice (Razani, Combs, et al., 2002), cavin-1 null mice and
Cav-3 null mice, which lack caveolae in all tissues, developed insulin resistance at an early age
(Capozza et al., 2005) presumably due to a defect in insulin signaling and/or glucose uptake (L.
Liu et al., 2008). Moreover, although the mechanism is not fully understood, CAV1 (gene
encodes Cav1 protein) genetic variants have been linked to familial lipodystrophies (Garg &
Agarwal, 2008; Garg et al., 2015; Schrauwen et al., 2015).
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In this study, we used a genetic approach in mice and in human induced pluripotent stem
cells (iPSC) to investigate the role of NKA α1 and its association with Cav1/caveolae in
adipocyte biology.
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Abstract
Deficiencies in mice and humans have brought to the fore the importance of the caveolar
network in key aspects of adipocyte biology. The conserved N-terminal caveolin binding motif
(CBM) of the ubiquitous Na/K-ATPase (NKA) α1 isoform, which allows NKA/Cav1 interaction,
influences NKA signaling, caveolar distribution, and embryonic development of the mouse.
However, its role in postnatal adipogenesis is not known.
This was examined in CBM null mutant (mCBM) heterozygous mice as well as in human
induced pluripotent stem cells (iPSCs) obtained through CRISPR/Cas9 genome editing.
Heterozygous mCBM mice had altered adiposity and adipose fibrosis. Mutant mCBM iPSC were
able to differentiate into adipocytes but histological, qPCR, western blotting and functional
analyses using Seahorse metabolic flux analysis revealed profound defects. Specifically, mCBM
cells had a significantly reduced lipid content, mitochondrial and caveolar anomalies, and
extracellular matrix (ECM) remodeling,
Mechanistically, total Na/K-ATPase activity was unchanged in mCBM cells. A TGF-βdependent increase of cellular redox, ECM remodeling markers, and reduction of lipid storage
occurred in mCBM cells and was prevented by lentiviral expression of a wild-type mouse NKA
α1 with intact CBM. Pharmacological normalization of mitochondrial using MitoTempo
ameliorated lipid storage in mCBM cells but did not substantially affect ECM remodeling.
Consequently, it is concluded that the CBM on NKA α1 is critical for the maintenance of low
ECM stiffness and fibrosis via a TGF-β-dependent mechanism. This in turn favors metabolic
homeostasis and adequate lipid storage in the adipocyte.
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Beyond the new function of CBM, this result is another evidence of the importance of
ECM and fibrosis for adipose structure and function, which has been increasingly recognized in
obesity and related disorders.
One Sentence Summary: Na/K-ATPase α1 regulates extracellular matrix remodeling and
adipogenesis via its conserved N-terminal caveolin binding motif.
Introduction
The initial report of significant adipose defects in caveolin-1 (Cav1) null mice, which
lack caveolae, brought about the importance of the caveolar network in adipose structure and
function (Cohen, Combs, Scherer, & Lisanti, 2003; Cohen, Schubert, Brasaemle, Scherer, &
Lisanti, 2005; Razani, Combs, et al., 2002). Indeed, Cav1 null mice have smaller fat pads, a
defective lipid metabolism, and do not develop high fat diet-induced obesity (Cohen, Razani, et
al., 2003). At the molecular level, studies have shown the role of the caveolar network in key
physiological functions of the adipocyte, such as the regulation of membrane vesicle trafficking,
lipid homeostasis, and signal transduction (Cohen, Combs, et al., 2003; Pilch & Liu, 2011). As
clinical reports continue to document the role of Cav1 and other key structural components of
caveolae in lipodystrophies (Garg & Agarwal, 2008; Schrauwen et al., 2015), understanding the
complex dynamics that govern caveolae structure and functions in the adipocyte has also become
a translational aspiration.
Both α1 and α2-containing isoenzymes of Na/K-ATPase (NKA) are expressed in the
mammalian adipocyte. While it has long been established that isoenzymes function as ionpumping machinery that ensures the transport of Na+ and K+ across the cell membrane (Morth et
al., 2011; Skou, 1957; Skou & Esmann, 1992), there are clear isoform-specific distinctions in
their ability to carry on non-ion-pumping functions of NKA (Kutz et al., 2021; J. Xie et al.,
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2015). The conserved N-terminal Cav-binding motifs (CBM) on NKA α1 allows NKA to
interact with Cav1, regulate Cav1 trafficking and cell membrane caveolae number, and influence
cell membrane cholesterol distribution (Y. Chen et al., 2009; H. Wang et al., 2004). The loss of
CBM function in the NKA α1 subunit, which we have obtained through F97A/F100A double
mutagenesis, disrupts its ability to act as a scaffold and a signaling receptor (Cai et al., 2008; X.
Wang et al., 2020), but does not interfere with its role as a Na+/K+ pump (Cai et al., 2008; H.
Wang et al., 2004; X. Wang et al., 2020).
To our knowledge, the physiological role and impact of the Cav1/NKA α1 interaction in
the adipocyte are unknown. However, previous studies suggesting that pharmacological
inhibition of NKA-mediated signal transduction influence adipose-related mechanisms such as
adipogenesis of 3T3-L1 cells or high-fat diet-induced obesity and related complications in mice
(J. Liu et al., 2016; Pratt et al., 2019; Sodhi et al., 2015; Sodhi et al., 2018; Sodhi et al., 2017;
Yan et al., 2019) prompted us to hypothesize that Cav1/NKA α1 has a key role in the regulation
of adipose function.
This was tested using a genetic approach in mice and in human induced pluripotent stem
cells exposed to a protocol of adipocyte differentiation in vitro. Collectively, the contrasting
results obtained in wild-type (WT) vs F97A/F100A CBM mutant (mCBM) mice and iPSC are
consistent with a regulatory role of NKA α1 CBM in adipogenesis that is related to control of
TGFβ signaling and extracellular matrix remodeling. This impacts cell caveolar and
mitochondrial networks, redox status, and ultimately cell metabolism, insulin sensitivity, and
lipid storage. Although distinct, similarities noted between the phenotypic defect of adipose
structure in Cav1 genetic and NKA CBM mouse models suggest that NKA scaffolding/signaling
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function may be relevant in the setting of familial lipodystrophies associated with caveolar gene
polymorphisms.
Results
Reduced fat mass, inflammation, and fibrotic remodeling in the mCBM mouse
Using a LoxP targeting strategy, we have developed a mutant mouse carrying the double
F97A; F100A substitution in Atp1a1, which encodes NKA 1 (X. Wang et al., 2020). The CBM
mutation of Atp1a1 was embryonic lethal for homozygotes, but heterozygote mCBM mice
survived to adulthood without overt phenotypic abnormality under basal laboratory conditions
(X. Wang et al., 2020). Given the importance of NKA signaling and caveolar integrity in
metabolic diseases (Sodhi et al., 2015; Sodhi et al., 2017), the adipose tissue of heterozygous
mCBM mice (henceforth referred to as mCBM mouse) was further examined.
The weight of WT and mCBM male mice, recorded weekly between the age of 6 and 23
weeks, did not reveal any significant difference in growth between the two genotypes (Fig. 15A).
However, Echo MRI analyses did reveal a significant reduction of over 30% of total fat mass in
mCBM mice, which was compensated by an increase in lean mass (Fig. 7A). This was not
related to an apparent change of food intake (Fig. 15C), and direct measurement of visceral and
subcutaneous fat mass (Fig. 15B) further indicated that the reduction was uniformly distributed
among fat depots. Histological analysis of the epididymal white adipose tissue (WAT) following
Hematoxylin & Eosin (H&E) staining indicated that the reduced fat content in mCBM mice was
associated with reduced size of their adipocytes (Fig 7B&C). Crown-like structures (CLS), a
hallmark of proinflammatory activation in the adipose tissue formed by recruitment of
macrophages around dead or dying adipocytes (Cinti et al., 2005; Murano et al., 2008), were
essentially absent from WT preparations but detected in a high number in the mCBM adipose
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tissue (Fig. 7B &C). Chronic inflammation in mCBM WAT was further indicated by
macrophage marker F4/80 staining (Fig. 7B&C), and increased gene expression of
proinflammatory cytokines TNF-α and IL-6 (Tnfα and Il6) in WAT from mCBM mice (Fig. 7D).
This suggested macrophage infiltration/recruitment, accompanying inflammation in fat tissue.
Masson’s Trichrome staining revealed an increased collagen deposition, suggestive of fibrotic
remodeling (Fig. 7B). Consistently, type 1 collagen and fibronectin 1 gene expressions (Col1a1
and Fn1, respectively) were elevated in mCBM WAT (Fig. 7D). Accordingly, we concluded
from this set of experiments that adipose tissue remodeling occurred in the mCBM mouse. As
observed in pig epithelial cells expressing the CBM mutant NKA (X. Wang et al., 2020), an
alteration of the caveolar network (Fig. 8A&B) and redistribution of NKA and Cav1 away from
the caveolar fractions (Fig. 8C&D) were detected in mCBM WAT. This was accompanied by a
reduction of NKA α1 protein with an apparent compensatory increase of NKA α2 and Cav1 total
protein expression (Fig 8E&F). Given these structural changes and the importance of caveolae
function in adipose biology, perturbation of the cellular NKA/caveolae axis in the adipocyte
itself likely contributes to adipose tissue remodeling in the mCBM mouse. To test this explicitly,
we submitted WT and mCBM human pluripotent stem cells iPSC to an adipocyte differentiation
protocol in vitro.
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Figure 7. Fat remodeling in mCBM heterozygous mice.
A) Body composition of mCBM heterozygous and WT mice at age of 6-month, n=4. B)
Representative H&E staining, Masson’s trichrome staining, and F4/80 staining of epididymal fat
from WT or mCBM heterozygous mice. Representative pictures are selected from n=4-6 mice in
each group, scale bar = 200μm. C) Quantitation of average cell size, crown-like structure
number, and F4/80 positive cells in panel A. D) The mRNA levels of Tnfα, Il6, Col1a1, and Fn1
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in WAT by RT-qPCR, n=3-5. Data reported as mean ± SE. *, P < 0.05; **, P < 0.01; ***,
P < 0.001 (Unpaired t-test with Welch's correction)
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Figure 8. Reduced caveolae in adipocytes isolated from mCBM heterozygous mice.
A) Electronic microscope images showing caveolae structure in the adipocyte plasma membrane
of mCBM heterozygous mice. Black arrows: membrane-associated caveolae; Red arrows:
membrane-dissociated caveolae, and B) quantitation of membrane-associated caveolae and total
caveolae numbers per μm. Representative pictures were selected from n=4 mice. C) Protein
distribution in WT and mCBM heterozygous mice epididymal WAT and D) Quantitation of
NKA α1 and Cav1 in fraction 4/5, n=3. E) Western blot of NKA α1, NKA α2, and Cav1 in
epididymal WAT of WT and mCBM mice and F) Western blot quantitation, n=3. Data reported
as mean ± SE. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Unpaired t-test with Welch's correction)
Structural remodeling in human iPSC-derived mCBM adipocytes.
The generation of NKA CBM mutant iPSC has been reported previously (X. Wang et al.,
2020). Wild-type (WT) and mCBM iPSC were subjected to a well-characterized adipogenesis
protocol, consisting of two sequential differentiation steps (iPSC-to-MSC, followed by MSC-toadipocyte) as summarized in Fig. 16A (Hafner & Dani, 2014; W. Tang et al., 2008). Marker gene
expression was measured by RT-qPCR before and after the first 2 weeks of mesenchymal
differentiation. The loss of stemness in mCBM iPSC, which has been previously reported (X.
Wang et al., 2020), was confirmed by altered expression of the stem cell marker gene SOX2
(Fig. 16B). However, the expression of adipocyte progenitor marker genes PDGFRA and
PDGFRB was detected in mCBM cells (Fig. 16B), suggesting that mCBM parental iPSCs have
already moved from the original pluripotent state into a more differentiated state but may still
have the potential to differentiate into adipocytes. After a total of five weeks of adipocyte
differentiation, a robust expression of the dominant adipogenesis marker gene PPARγ and the
gene encoding the key de novo lipogenesis enzyme fatty acid synthase (FASN) was detected in
both WT and mCBM cells. Elevated levels of adipocyte-specific genes ADIPOQ (which encodes
Adiponectin) and FABP4 (which encodes Fatty Acid Binding Protein 4) were also measured in
mCBM cells (Fig. 9C). This indicated that both WT and CBM mutant iPSCs successfully
committed to the adipocyte lineage. However, Oil Red O staining indicated a drastic reduction of
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lipid accumulation in mCBM iPSC-derived adipocytes 3 weeks after adipogenesis induction
(Fig. 9A&B). This was confirmed by electron microscopy, revealing a 75% reduction of the
number of lipid droplets (LD) per cell (Fig. 9D&E).
To probe the molecular mechanisms behind the defective adipogenesis in mCBM cells,
we used RNA-seq analysis as an unbiased approach. Among a total of 48163 scanned genes,
over 5000 genes were differentially expressed (volcano plot, Fig. 17A). KEGG enrichment
indicated a global up-regulation of genes in pathways associated with ECM fibrotic remodeling,
including genes related to glycosaminoglycans biosynthesis and focal adhesion (Fig. 17B).
Consistently, fibrotic remodeling was observed by fluorescence imaging, with a marked increase
in type I collagen deposition in mCBM adipocyte cultures (Fig. 9F). This was corroborated by
increased expression of fibrosis marker genes COL1A1 (collagen type I, α1) and FN1
(fibronectin) (Fig. 9G). Importantly, as observed in the fat tissue of mCBM mice, mCBM
adipocytes had a reduced expression of NKA α1 with upregulation of NKA α2 (Fig. 10A&B),
without change of Na/K-ATPase-dependent enzymatic activity compared to WT adipocytes (Fig.
10C). Moreover, consistent with the previous observation that mCBM does not affect the
enzymatic function of NKA (X. Wang et al., 2020), Na/K-ATPase activity was not changed in
mCBM iPSC or derived adipocytes (Fig. 10C). As in mCBM fat, increased expression of Cav1
was detected in mCBM adipocytes (Fig. 10A). Hence, the anomalies observed in mouse mCBM
fat were phenocopied with a high level of similarity in human IPSC-derived mCBM adipocyte
cultures, indicative of a profound role of caveolar NKA signaling in adipose physiology.
Consistently, lentiviral-mediated expression of WT mouse NKA α1 in mCBM iPSC prior to
exposure to the adipogenesis protocol significantly rescued lipid accumulation (Fig. 10D&E),
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reduced collagen deposition (Fig 10F), and decreased fibrosis marker genes expression (Fig
10G), indicative of a causal role of NKA α1 in the observed functional defects.

Figure 9. Adipogenesis impairment in mCBM human induced pluripotent stem cell (iPSC)
derived adipocytes.
A) Oil Red O staining of iPSC-derived adipocytes, representative pictures are selected from n=4
independent repeats. Scale bar=500μm B) Quantification of Oil Red O Staining C) Expression of
adipogenesis marker genes before (MSC) and after (Adi) 3 weeks of adipogenesis by RT-qPCR,
n=3-6. D) Electron Microscopy (EM) images of WT and mCBM iPSC-derived adipocytes, and
E) quantitation of lipid droplet (LD) per cell, n=8. Representative pictures are selected from 3
independent repeats. Scale bar=2μm F) Collagen deposition in WT and mCBM iPSC-derived
adipocytes. Blue: DAPI staining for nuclear, Red: Immunostaining of type I collagen.
Representative pictures are selected from n=3 independent repeats. Scale bar = 500 𝜇m. F)
mRNA levels of COL1A1 and FN1 genes in WT and mCBM iPSC-derived adipocytes measured
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by RT-qPCR, n=4. Data reported as mean ± SE. *, P < 0.05; **, P < 0.01; ***, P < 0.001
(Unpaired t-test with Welch's correction)

Figure 10. NKA in iPSC-derived Adipocytes.
A) Western blot of NKA α1, NKA α2, and Cav1 in WT and mCBM iPSC-derived adipocytes
and B) Western blot quantitation, n=3. C) Ouabain sensitive ATPase activity in WT and mCBM
iPSCs and iPSC-derived adipocytes, n=4. D) Oil Red O staining of iPSC-derived adipocytes,
representative pictures are selected from n=4 independent repeats. Scale bar=200μm and E)
Quantitation of Oil Red O staining. Mouse α1 was introduced into mCBM iPSC via lentivirus
vector. F) Collagen deposition in iPSC-derived adipocytes. Red fluorescence indicates type I
collagen. Representative pictures are selected from n=3 independent repeats. Scale bar = 200μm.
G) The mRNA levels of COL1A1 and FN1 gene in iPSC-derived adipocytes measured by RTqPCR, n=4. Data reported as mean ± SE. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Unpaired ttest with Welch's correction and one-way ANOVA with Tukey post hoc test)
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Impaired metabolism, mitochondrial function, and redox state in the mCBM adipocyte.
In addition to an upregulation of genes in pathways related to ECM remodeling, our
KEGG enrichment analysis indicated a significant down-regulation of metabolic genes,
including those related to insulin signaling and tricarboxylic acid cycle (TCA) cycle, in mCBM
adipocytes (Fig. 17B). This was explored functionally by evaluating cellular glycolysis and
mitochondrial respiration using Seahorse metabolic flux analysis. Baseline extracellular
acidification rate (ECAR) monitoring indicated a reduction of both basal glycolysis rate
(measured in the presence of glucose) and maximum glycolytic capacity (measured in the
presence of glucose and oligomycin to inhibit mitochondrial respiration) in mCBM adipocytes
(Fig. 11A&B). Hence, mCBM adipocytes were able to metabolize glucose in the conditions of
our Seahorse assay, but glycolysis was defective. However, this did not exclude a possible defect
in insulin signaling. The RNA-seq KEGG enrichment analysis (Fig. 17B) pointed to such defect,
which was corroborated at the mRNA and protein level by decreased expression of insulin
receptor (IR), insulin receptor substrate (IRS), and glucose transporter 4 (GLUT 4) (Fig. 11C-E).
Functionally, an alteration of the cell membrane distribution of GLUT 4 (Fig. 11F, yellow arrow)
and a reduction of acute stimulation of glucose uptake (Fig. 11G) in response to insulin
confirmed altered insulin signaling in mCBM adipocytes. Since long-term insulin exposure is
key to the maintenance of glycolytic capacity in adipocytes (Klip, McGraw, & James, 2019), this
impaired insulin signaling pathway likely contributes to the overall reduction of glycolytic
capacity in mCBM adipocytes. Consistent with this notion, intracellular GLUT4-enriched
vesicles (Fig. 11F, red arrow), which typically form upon long-term insulin stimulation, were not
observed in the mCBM iPSCs-derived adipocytes. Of note, the reduction of basal and maximal
glycolytic capacity in mature mCBM adipocytes maintained in insulin-containing media was
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also present in the absence of insulin (Fig. 18A&B). Because the increase in glycolytic enzyme
expression that normally occurs with consistent insulin stimulation during adipogenesis is likely
blunted in the insulin-resistant mCBM adipocyte, a persistently decreased glycolytic capacity
was not unexpected. The reduced gene expression of phosphofructokinase (PFKM), a key
insulin-induced glycolytic enzyme, in mCBM adipocytes is consistent with this hypothesis (Fig.
11C).
The maximum respiratory capacity measured by Seahorse analysis was preserved in
mCBM adipocytes. However, the ATP-synthesis coupled respiration rate was significantly
reduced, associated with reduced ATP5A1 gene expression (Fig. 12G), without change of
maximum respiratory capacity or spare capacity (Fig. 12A&B). These indicate a defect of
mitochondrial respiration and ATP production in mCBM adipocytes likely to contribute to the
metabolic defect. Electron microscopy revealed mitochondrial enlargement (Fig. 12C&D), a
phenotype reminiscent of the Cav1-/- mouse adipose tissue that has been associated with
mitochondrial dysfunction (Cohen et al., 2005). These mitochondrial abnormalities occurred
with an increase of about 70% in mitochondrial ROS production in mCBM adipocytes, as
indicated by mitoNeoD staining. Taken together, these observations were consistent with a
profound mitochondrial dysfunction with increased mitochondrial and extramitochondrial ROS
generation in mCBM adipocytes. Such perturbations of the cellular redox status have been
associated with profound alterations of adipose physiology and could be key to the mCBM
mouse fat phenotype (Fig. 7). Indeed, elevated oxidative stress has been shown to lead to adipose
tissue fibrosis, and tissue fibrosis itself has been shown to further enhance oxidative stress (Sun
et al., 2013). This positive feedback loop has been shown to eventually result in chronic
inflammation, insulin resistance, and metabolic dysfunction of the adipose tissue (Sun et al.,
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2013). Activation of HIF-1α and increased downstream inflammatory cytokines (IL6, encode
Interleukin 6, and CCL2, encode monocyte chemoattractant protein-1) mRNA further indicated a
stressed intracellular environment in mCBM adipocytes compatible with this model (Fig
12F&G). To further clarify the role of mitochondrial ROS in the mCBM adipocyte, we pretreated mCBM MSC with the mitochondrial ROS scavenger MitoTEMPO for 72 h before
initiation of the adipogenesis phase of the differentiation protocol (Fig. 16A). The MitoTEMPO
treatment dose-dependently improved lipogenesis in mCBM cells (Fig. 12H) but did not prevent
ECM collagen deposition (Fig. 12I&J). Taken together, these data suggested that ECM
remodeling preceded mitochondrial redox imbalance and defective lipogenesis during mCBM
adipocyte differentiation. Consistent with this, collagen staining and fibrosis markers gene
expression (COL1A1 and FN1) indicated an early onset of ECM remodeling in precursor mCBM
iPSCs (Fig. 19A&B) and MSCs (Fig. 20A&B), which was rescued upon lentiviral-mediated
expression of WT mouse NKA α1 (Fig. 19A&B). Moreover, the increased NADPH/NADP ratio
confirms the hypoxia condition and change of redox state in mCBM iPSCs, and this change is
restored by exogenous WT NKA α1 (Fig. 19C).
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Figure 11. Glycolysis Defect and Insulin Resistance in mCBM Adipocytes.
A) Seahorse XF Cell Glycolysis Test in WT and mCBM iPSC-derived adipocytes, in the
presence of insulin. Respectively, glucose, Oligomycin, and 2-DG were added to the cells after
the basal ECAR was established (as indicated by arrow). The data are normalized by protein
amount as mpH/min/Norm. Unit. B) Quantitation of panel A, n=9. C) mRNA levels of insulin
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receptor (INR), insulin receptor substrate (IRS), GLUT4, and PFKM genes measured by RTqPCR, n=3-4. D) Western blot of the protein expression level of insulin receptor substrate 1
(IRS1), insulin receptor 𝛽 subunit (IR𝛽), and GLUT4 in mCBM adipocytes, E) Quantitative
analyses of IR𝛽, IRS, and GLUT4 expression by WB. Data are normalized by 𝛼-tubulin level
and % of WT control. n=4-6. F) Immunostaining pictures of mCBM and WT iPSC-derived
adipocytes in adipogenesis medium containing 0.1% human insulin. Green: immunostaining of
GLUT4; Blue: DAPI staining for cell nuclei; Red arrow: GLUT4 packed in vesicles; Yellow
arrow: GLUT4 on the cell membrane. Representative pictures were selected from n=3 repeats.
G) Mean fluorescence intensity (MFI) of Glucose Uptake Assay in WT and mCBM adipocytes
by 10 μM 2-NBDG with 0.1% insulin in the serum-free DMEM for 3h, no insulin group as
empty control. n=4/group. **P < 0.01 vs untreated. Data reported as mean ± SE. *P < 0.05,
**P < 0.01, ***P < 0.001 (Unpaired t-test with Welch's correction)
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Figure 12. Metabolic dysfunction in mCBM adipocytes.
A) Seahorse XF Mito Stress Test in WT and mCBM iPSC-derived adipocytes. Respectively,
Oligomycin, FCCP, and RA were added to the cells after the basal OCR was established (as
indicated by arrows). The data are normalized by protein amount as pmol/min/Norm. Unit. B)
Quantitation of Panel A, n=12-18. C) Mitochondrial EM images of WT and mCBM iPSCderived adipocytes. Representative pictures are selected from n=3 independent repeats. Scale
bar= 500 nm. D) Mitochondrial area relative frequency of WT and mCBM iPSC-derived
adipocytes. Data are quantified from EM images in panel B. E) Mitochondrial ROS generation in
WT and mCBM iPSC-derived adipocytes are detected by mitochondria-targeted superoxide
probe MitoNeoD. Data show signal intensity measured with fluorescence-activated cell sorting
(FACS) and were normalized by WT control, n=3. F) Western blot band of HIF-1𝛼 and 𝛼 tubulin
as loading control in WT and mCBM iPSC-derived adipocytes and quantification of western blot
bands, n=3. G) mRNA levels of ATP5A1, HIF-1𝛼, IL6, and MCP-1 genes in WT and mCBM
iPSC-derived adipocytes measured by RT-qPCR, n=3-6. H) Quantification of Oil Red O staining
of lipid on mCBM iPSC-derived adipocytes pre-treated with 0, 5, 25, 100 nM MitoTEMPO, n=4.
I) Collagen deposition in iPSC-derived adipocytes. Red: Immunostaining of type I collagen,
Blue: DAPI. Representative pictures are selected from n=3 independent repeats. Scale bar = 500
𝜇m. J) mRNA levels of COL1A1 and FN1 genes in iPSC-derived adipocytes measured by RTqPCR, n=3-4. The data were reported as mean ± SE. Data reported as mean ± SE. *, P < 0.05; **,
P < 0.01; ***, P < 0.001 (Unpaired t-test with Welch's correction and one-way ANOVA with
Tukey post hoc test)

49

ECM remodeling alters lipogenesis in mCBM adipocytes.
NKA-mediated signaling is well known as a potent regulator of collagen synthesis, ECM
remodeling, and tissue fibrosis in cardiac and renal diseases (Fan, Xie, & Tian, 2017; Quintas et
al., 2010). The above studies in mice and human iPSC-derived adipocytes suggest that
disassembly of the caveolar NKA signaling complex upon mutation of the NKA’s CBM led to
unchecked ECM remodeling, increased oxidative stress, inflammation, and metabolic
abnormalities that ultimately altered lipogenesis. During mesenchymal differentiation,
adipogenesis and fibrogenesis counteract each other (Sun et al., 2013). Indeed, ECM stiffness is
critical for MSC lineage commitment (Engler et al., 2006; Rowlands et al., 2008). Mesenchymal
ECM must adopt a flexible structure with a remarkable reduction of fibrotic collagen type I to
allow expansion of the adipocyte (Chun et al., 2006; Sun et al., 2013; Winer et al., 2009), while
activation of potent profibrotic cytokines such as TGF-β induces expression of fibrosis marker
genes in mesenchymal progenitor cells, increases the amount of collagen type-I-producing cells,
and inhibits adipogenesis (Bortell, Owen, Ignotz, Stein, & Stein, 1994; Carthy, 2018; Choy,
Skillington, & Derynck, 2000). Such fibrotic ECM also creates hypoxic conditions that further
activate the HIF1-α signaling pathway, and inhibits metabolic functions of adipocytes (Sun et al.,
2013), as observed in the mCBM adipocytes. Consistent with this model, TGF-β gene expression
was increased in mCBM iPSC and repressed upon lentiviral delivery of WT NKA α1 (Fig. 19B).
Crosstalk between TGF-β signaling and Na/K-ATPase has been reported in various experimental
studies (Grigorova et al., 2018; Kennedy et al., 2018; La et al., 2016). To functionally evaluate
the role of this crosstalk in the adipogenesis defect of mCBM cells, we tested whether inhibition
of TGF-β signaling attenuates ECM remodeling/fibrosis in mCBM cells, thereby rescuing
adipogenesis. Accordingly, WT and mCBM iPSCs were first treated with 100 μM TGF-β
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inhibitor SB431542 for 24 h. As shown in Fig. 21A, SB431542 treatment reduced ECM stiffness
in iPSCs, significantly decreased fibrosis marker gene expression (Fig. 21B). Importantly,
SB431542 treatment also reduced the elevated NADPH/NADP ratio in mCBM iPSC (Fig. 21C),
suggesting that hypoxia and altered redox state in mCBM iPSCs is secondary to TGF-β
dependent ECM remodeling. To further test the effect of SB431542 on adipogenesis of mCBM
cells, 10 μM of SB431542 were added to the adipogenesis cocktail during the three weeks of the
adipogenesis protocol (Fig. 16A). Significantly, lipid accumulation was increased in mCBM
adipocytes exposed to the SB431542 treatment (Fig 13A&B). Additionally, SB431542 decreased
ECM stiffness, fibrosis marker gene expression (COL1A1 and FN1), and the expression of
HIF1A in mCBM adipocytes (Fig 13C&D).

Figure 13. TGF-β inhibitor (TGFi) SB431542 rescues adipogenesis in mCBM cells.
A) Oil Red O staining of iPSC-derived adipocytes, representative pictures are selected from n=4
independent repeats. Scale bar=200μm and B) quantitation of panel A, n=4. C) Collagen
deposition in iPSC-derived adipocytes. Red: Immunostaining of Type I collagen. Representative
pictures are selected from n=4 independent repeats. Scale bar = 500 𝜇m. D) mRNA levels of
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COL1A1 and FN1 genes in iPSC-derived adipocytes measured by RT-qPCR, n=4. Data reported
as mean ± SE. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (One-way ANOVA with Tukey post hoc
test)

Collectively, these studies provide the first genetic evidence of a critical role of caveolar
NKA signaling in adipose biology. Mechanistically, this role does not appear to be related to a
change in ATPase-driven ion-transport function. Rather, the adipogenesis defect secondary to the
loss of CBM appears to be a consequence of the dysregulation of a TGF-β-dependent control of
ECM stiffness, redox status, and inflammation, which ultimately leads to inadequate metabolic
function during adipogenesis (Fig. 14).

Figure 14. Role of NKA-Cav1 binding in adipogenesis.
NKA-Cav1 binding is essential for maintaining the ECM stiffness in stem cells. Loss of NKACav1 binding increases ECM stiffness. The fibrotic ECM further activates HIF-1α and
eventually results in metabolic dysfunction during adipogenesis.
Discussion
NKA is one of the most critical housekeeping genes in mammals. Besides its traditional
role as an ion pump, accumulating evidence has shown the non-ion pumping function of the α1
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NKA subunit is also essential in cell physiology. Here, we report that the conserved NKA-Cav1
interaction is a critical regulator of adipogenesis. The NKA/Cav1 interaction, which has been
shown to allow the formation of an NKA/Cav1/Src signal complex and its integration with other
proteins in epithelial cells, was studied in the context of adipogenesis. Our results suggest that
NKA/Cav1 interaction is important for collagen production, mitochondrial function, ROS
generation, and further ensures regular adipogenesis and adipocyte metabolism. Specifically, our
studies in CBM mutant adipocytes indicate that increased ECM stiffness activates HIF-1α and its
downstream pathway, results in elevated oxidative stress, insulin resistance, and metabolic
dysfunction. These defects eventually cause impaired adipogenesis (Fig. 14). This is the first
genetic evidence of NKA-mediated regulation of adipogenesis.
NKA/Cav1-binding regulates Cav1 trafficking and caveolae formation. The cell
membrane-associated caveolae in the adipocyte are critical for adipocyte function and the
development of lipodystrophy (Garg & Agarwal, 2008; Garg et al., 2015). Both the number of
total caveolae and the number of membrane-associated caveolae were reduced in adipocytes
from mCBM (Fig.16A&B), which is similar to the adipose tissue phenotype of lipodystrophy
patients (Garg et al., 2015). Lipodystrophies include genetic disorders characterized by reduced
fat mass and adipose metabolic dysfunction (Brown et al., 2016). They can be caused by genetic
defects leading to altered adipogenesis, and patients also exhibit metabolic defects in cell
respiration, elevated intracellular stress, and cell apoptosis (Schrauwen et al., 2015). CAV1 is
known as one of the loci for genetic lipodystrophies in humans (Garg & Agarwal, 2008).
Moreover, the Cav1 -/- mice also show adipose tissue dysfunction including insulin resistance,
cell respiratory defects, and impaired metabolism (Cohen, Razani, et al., 2003). These findings
have suggested a fundamental role of Cav1 in adipose biology, which was not fully understood.

53

In this study, we first time reported the mechanistic role of NKA CBM in the regulation of
adipogenesis, this fulfills the puzzle of how the loss of Cav1 function associate with
adipogenesis defect. However, none of the NKA mutations were reported to cause genetic
lipodystrophy, possibly due to the more essential role of NKA in survival. While the NKA CBM
homozygous mutation is embryonic lethal, the Cav1 -/- mouse can survive to adulthood (Cohen,
Razani, et al., 2003; X. Wang et al., 2020). In addition, although both Cav1 knockout and NKA
CBM mutant caused adipose insulin resistance, the Cav1 knockout shows defect in insulin signal
transduction without change of protein expression in the insulin signaling pathway (Cohen,
Razani, et al., 2003), and the NKA CBM mutant adipocytes exhibited a decrease in total gene
and protein expression in the insulin signaling pathway. Moreover, a previous study on NKA α1
+/- mouse shows no difference in fat mass, which indicates the altered adiposity is a consequence
of CBM mutation rather than decreased NKA α1 expression (Kutz et al., 2018). This implied a
manner-dependent regulation of NKA/Cav1 distribution is more critical than the expression of
Cav1 or NKA in organogenesis and adipose function.
Although we have identified the mechanistic role of NKA CBM in the regulation of
adipogenesis through manipulation of ECM remodeling and metabolic function, the molecular
details remain a blur. Adipose tissue fibrosis was recently recognized to contribute to the
dysfunctional adipose tissue in obesity and related disorders (Bielczyk-Maczynska, 2019; Sun et
al., 2013). The cardiotonic steroids-induced tissue fibrosis through NKA/Src-mediated signaling
was well documented in the cardiac and renal model, but not yet in the adipose tissue (Elkareh et
al., 2007; Elkareh et al., 2009; L. V. Fedorova et al., 2009; Kennedy et al., 2006; Shapiro & Tian,
2011; Tian, Shidyak, et al., 2009). Whether the loss of NKA CBM induced adipose fibrosis
through a similar mechanism remains unknown. The NKA/Cav1 binding is essential for the
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formation of cell membrane NKA/Src complex (Cai et al., 2008; H. Wang et al., 2004), loss of
CBM may alter the dynamic regulation of NKA-mediated signal transduction in adipocyte.
Besides, loss of CBM also alters the cellular distribution of NKA and Cav1 (Cai et al., 2008).
The scaffolding function of Cav1 is critical for both ECM remodeling (Castello-Cros et al., 2011;
Del Galdo et al., 2008; Drab et al., 2001; Razani et al., 2001; X. M. Wang et al., 2006) and lipid
metabolism (Lockwich et al., 2000; Ostermeyer et al., 2004; Pilch & Liu, 2011; Pilch et al.,
2011), which could be disturbed by the loss of CBM induced Cav1 redistribution and
independent of Src. Pharmaceutical inhibition of the NKA/Src/ERK axis can reduce the adipose
tissue oxidative stress in obese mice, and therefore benefits metabolic symptoms (Sodhi et al.,
2015; Sodhi et al., 2017). The manipulation of intracellular ROS via NKA/Src/ERK signaling
was thought to be critical for this therapeutic effect (Pratt et al., 2019). However, mitochondrial
ROS scavenger failed to rescue the adipogenesis defects in mCBM. Our data has shown the
NKA CBM regulates adipogenesis through ECM remodeling over ROS generation. This implies
the Src-independent function of NKA CBM. Evolutionarily, the gain of the caveolin binding site
on NKA occurred at the same time as the acquisition of the binding sites for sodium and
potassium (X. Wang et al., 2020), which is much earlier than the NKA/Src binding. This
confirms the critical role of NKA CBM in mammal species survival. Taken together, the CBM is
more essential for the post-embryonic development of adipose tissue, and the NKA/Src/ERK
axis may be more specific in the regulation of ROS-associated signaling in adipocytes.
Materials and Methods
Reagents
bFGF, Gibco #1949360
Serum knock out replacement, Gibco #10828010
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Human insulin, Sigma #I9278
Dexamethasone, Sigma #D1756
Indomethacin, Sigma #I7378
3-Isobutyl-1-methylxanthine (IBMX), Sigma #I5897
Rosiglitazone, Sigma #2408
Alamethicin, Sigma #A4665
Ouabain, Sigma #O3125
Adenosine 5-triphosphate magnesium (ATP/Mg), Sigma #A9178
mCBM Mouse
Animal protocols were approved by the Marshall University Institutional Animal Care and Use
Committee (IACUC) according to National Institutes of Health (NIH) guidelines. The mCBM
heterozygous mice were generated as previously described by Wang et al. (X. Wang et al.,
2020). In short, a LoxP-neomycin-LoxP cassette knockdown and rescue protocol was used to
generate a mouse line that expresses the CBM F97A and F100A mutant 1 NKA. All mCBM
heterozygous mice were backcrossed to C57BL6 for at least six generations.
Body composition
As described by Parkman JK, et al.(Parkman et al., 2016), the body composition of mice was
measured by quantitative magnetic resonance imaging using an EchoMRI-100 whole-body
composition analyzer (Echo Medical Systems, Houston, TX). The device was provisionally
calibrated on traditional phantoms representing fat (canola oil), and water. The quantities
measured by EchoMRI were fat, lean, free water, and total water.
Adipose tissue collection and histology staining
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Mice were anesthetized with 50 mg/kg pentobarbital administered via IP injection. Epididymal
adipose tissue was collected, flash-frozen in liquid nitrogen, and stored at -80°C until used for
Western blot analysis, Na/K-ATPase activity, or qPCR. For histological staining, isolated tissues
were fixed in 10% neutrally buffered formalin for 24 hours and stored in 70% ethanol until
further processing. Transverse sections of visceral adipose tissue were subjected to H&E
staining, Trichrome staining, and F4/80 immunohistochemistry staining by Wax-It, Inc.
(Vancouver, Canada).
Human iPSCs
As previously described by Wang, et al. (X. Wang et al., 2020), human iPSCs were purchased
from iXCells (catalog no. 30HU-002) and cultured with the TeSR-E8 Kit (STEMCELL
Technologies Inc., catalog no. 05940). mCBM F97A and F100A mutant human iPSCs were
generated by CRISPRCas9 genome editing. The DNA plasmids for Cas9–green fluorescent
protein (GFP) (Addgene, no. 44719) and guide RNA (gRNA) cloning vector (Addgene, no.
41824) were from Addgene. sgDNA (single-guide DNA) and ssODN (single-stranded
oligodeoxynucleotides) were designed according to the published protocol (Ran et al., 2013).
The cloned Cas9-GFP vector inserted with sgDNA, along with ssODN, was transfected into
human iPS cells with a 4D nucleofector device. Single-cell sorting and plating were later
performed with FACS flow cytometry and the clones were selected and validated via genotyping
PCR and DNA sequencing. For exogenous NKA α1 rescue, mouse Atp1a1 (NM_144900.2) was
cloned into a lentiviral expression vector with the help of Vectorbuilder (Fig. 22A). The cloning
strategy and DNA construct are derived from our previous product (Pratt et al., 2019). We
validated transgene expression using real-time qPCR. (Fig. 22B)
Human iPSC-derived adipocytes
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For adipocyte differentiation, human iPSCs were incubated with an MSC differentiation medium
(DMEM+10%FBS and 2.5 ng/mL bFGF) for 7-10 days until a monolayer was formed. The
mature MSCs were then transferred to collagen-coated plates at the ratio 1:3 as passage 1 and
maintained with DMEM+10% FBS. MSCs within 3 passages were subjected to adipogenesis.
MSCs at 100% confluence were incubated with adipogenesis medium (DMEM+15% serum
knockout replacement, 0.1% human insulin, 125nM Dexamethasone, 0.2mM Indomethacin,
100μg/mL IBMX, and 5μM Rosiglitazone, see reagents section) for 3 weeks to fully
differentiated into adipocytes and then were subjected to further measurements (Hafner & Dani,
2014). For the MitoTEMPO treatment, cells were treated with MitoTEMPO (Sigma # SML0737)
with the final dosage of 0, 5, 25, 100nM for 3 days before induction of adipogenesis. For the
TGF inhibitor treatment, SB431542 (Selleckchem #S1067) with the final concentration 10nM of
is added to the adipogenesis medium during the 3 weeks differentiation.
Oil Red O Staining
Oil red O staining for adipocytes was conducted as follows: mature adipocytes after 3 weeks of
adipogenesis were washed twice with ice-cold PBS, then fixed with 4% formaldehyde for 10 min
at room temperature. The fixed cells were stained with 0.21% Oil Red O in 60% isopropanol for
10 min at room temperature, then washed twice with PBS before imaging. After imaging, the
cells were dried out at room temperature overnight, the staining was then washed down by 100%
isopropanol for 10 min at room temperature. Then the concentration of Oil Red O was measured
at OD 490 nm by Spectramax 190 Microplate Reader (Molecular Devices, Inc).
Electron Microscopy (EM) imaging
Epididymal fat tissues of 6 weeks old male mice were fixed with glutaraldehyde and
paraformaldehyde followed by osmium tetroxide and uranyl acetate, dehydrated in ethanol and
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embedded in epoxy. Sections were cut at about 90 nm thickness, stained with lead citrate, and
imaged on an FEI Techai 12 using a Gatan camera and software. Cultured cells were digested
with 0.25% trypsin, washed twice with PBS, and then fixed with Karnovsky's Fixative (2%
Paraformaldehyde, 2.5% Glutaraldehyde and 0.1M Sodium Phosphate Buffer. EMS Catalog
#15720) and store at 4℃. For transmission EM, as described by Erin M. Zeituni et al. (Zeituni et
al., 2016), samples were washed 3x5 min with PBS, rinsed in 0.1M cacodylate pH 7.4 embedded
in agarose (cells) then 1%Osmium tetroxide for 1 h in cacodylate, followed by washes in water,
cacodylate, and water again (2 × 10 min each) and then incubation in 0.05 m maleate, pH 6.5, for
10 min. Samples were then stained en bloc with 0.5% uranyl acetate in maleate for 1.5 h at room
temperature. After 10-min washes with water, samples were dehydrated through graded ethanol
dilution (35%, 2 × 10 min; 50%, 10 min; 75%, 10 min; 95%, 10 min; 100%, 3 × 10 min).
Samples were then washed with propylene oxide 4 x 15min before incubation in 1:1 propylene
oxide/resin for 1 h, followed by two 3 x 1h washes in 100% resin and a final embedding in 100%
resin at 55 °C overnight followed by 70 °C for 3 days. Sections were made with a Reichert
Ultracut-S (Leica Microsystems), mounted on naked 200 thin mesh grids, and stained with lead
citrate. Images were captured by a blind investigator, with a Phillips Tecnai 12 microscope and
recorded with a Gatan multiscan CCD camera using Digital Micrograph software. The
mitochondrial area was quantitated from at least 8 single cell fields/group, the numbers of
caveolae were quantitated from at least 40 fields from 5-6 mice. Quantitation was done by
ImageJ 1.52a (Wayne Rasband, National Institute of Health).
Ouabain-sensitive Na/K-ATPase Activity
As described by Lai et al. (Lai et al., 2013), cells were collected and homogenized in ice-cold
buffer A (150 mm sucrose, 5 mm HEPES, 4 mm EGTA, 0.8 mm dithiothreitol) and briefly
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sonicated. After centrifugation (800 × g for 10 min), the post-nuclear fraction was further
centrifuged (45,000 × g for 45 min) to obtain a crude membrane preparation. The crude
membrane pellet was resuspended in buffer A, and the protein content was determined.
Resuspended crude membranes were treated with alamethicin (0.1 mg/mg of protein) for 10 min
at room temperature and then added to the buffer containing 50 mm Tris (pH 7.4), 1 mm EGTA,
1 mm MgCl2, 25 mm KCl, 100 mm NaCl, 5 mm NaN3. After 15 min of preincubation at 37 °C,
ATP/Mg was added to a final concentration of 2 mM to start the reaction. The reaction continued
for 40 min and was stopped by adding 8% ice-cold trichloroacetic acid. Phosphate generated
during the ATP hydrolysis was measured by BIOMOL GREEN Reagent (Enzo Life Science,
Cat# BML-AK111). Ouabain-sensitive Na/K-ATPase activities were calculated as the difference
between the values obtained in the presence or absence of 1 mM ouabain.
Seahorse glycolysis test and mito-stress test
As previously described by Kutz et al (Kutz et al., 2021), cells were plated in Seahorse XFp cell
culture miniplates (Agilent # 103025-100) and subjected to both the mitochondrial stress test kit
(Agilent #103017-100) and the glycolytic stress test kit (Agilent #103010-100). The assay was
run by an Agilent Seahorse XF analyzer. In short, MSCs were plated on a sterile XFp plate in
triplicate at 1 × 105 total cells per well before the 3-week-induction of adipogenesis. For the
mitochondrial stress test, cells were stimulated in the following sequence: (A) oligomycin; (B)
carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP); (C) rotenone/antimycin A.
Respiratory parameters calculated included basal oxygen consumption rate (OCR), ATP
synthesis-coupled respiration, maximum respiratory capacity, spare respiratory capacity, and
non-mitochondrial respiration. The appropriate concentration of FCCP was determined by FCCP
titration as recommended by the manufacturer, and all experiments were performed with this
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concentration of FCCP (0.6 nM). For the glycolysis test, cells were stimulated in the following
sequence: (A) glucose; (B) oligomycin; (C) 2-Deoxy-D-glucose (2-DG). Glycolysis parameters
calculated included basal Extracellular Acidification Rate (ECAR) and maximum glycolytic
capacity. For insulin-induced glycolysis, 0.1% human insulin is added to the glycolysis basal
medium. The ATP synthesis-coupled respiration is calculated as decrees of OCR after adding
oligomycin. The maximum respiratory capacity is calculated as an increase of OCR after adding
FCCP. The spare respiratory capacity is calculated as the increase of OCR with FCCP vs. basal
OCR. The non-mitochondrial respiration is calculated as the OCR after adding
rotenone/antimycin A. The basal glycolysis is calculated as an increase of ECAR after adding
glucose. The maximum glycolytic capacity is calculated as the ECAR after adding oligomycin.
Flow Cytometry Assays
As previously described in Chen Y, et al. (Y. Chen et al., 2019). For glucose uptake assay,
mature adipocytes after 3 weeks of differentiation were incubated in serum-free DMEM media
with 10μM 2-NBDG (Invitrogen, Cat#N13195) and 0.1% human insulin (Sigma, Cat#I-034) for
3h at 37℃. Cells were then lifted by scraping and suspended in 200μl buffer (PBS with 5% FBS
and 0.1% sodium azide) for flow cytometry. Intracellular fluorescence was quantified using the
FITC.
For measurement of mitochondrial ROS, mature adipocytes after 3 weeks differentiation
incubated in dMEM with10% FBS in the presence of 5μM MitoNeoD (Shchepinova et al., 2017)
for 15min at 37°C. At the end of incubation, cells were lifted by scraping and suspended in 200μl
buffer and immediately subjected to flow cytometry analysis. MitoNeoD fluorescence was
detected with the PE channel.
NADP/NADPH Ratio Quantitation
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The NADP/NADPH ratio was measured by NADP/NADPH Quantitation Kit (Sigma #MAK038)
according to the technical bulletin. In short, about 3 x 105 human iPSCs for each sample were
pelleted in a microcentrifuge tube and extracted with 600 μL of NADP/NADPH Extraction
Buffer, then placed on ice for 10min. Samples were centrifuged at 10,000g for 10 min, and
supernatants were transferred into another tube. For detection of total NADP, 50 μL of extracted
samples were added into 96-well plates in triplicate. To detect NADPH, 200 L of extracted
samples were aliquoted into microcentrifuge tubes and heat to 60 C for 30 minutes in a water
bath, then samples were cooled on ice. Under these conditions, all NADP will be decomposed
leaving NADPH only. 50 μL of NADPH (NADP decomposed) samples were transferred into
labeled 96-well plates in triplicate. 100 μL of the Master Reaction Mix (2 μL NADP Cycling
Enzyme Mix+98 μL NADP Cycling Buffer) were added to each of the standard and sample
wells. After 5 minutes of incubation at room temperature to convert NADP to NADPH, 10 μL of
NADPH developer were added into each well. Plates were incubated at room temperature for 1.5
hours. NADPH concentration was measured as the absorbance at 450 nm, the NADP/NADPH
ratio = (NADPtotal – NADPH)/ NADPH
Immunostaining
Adipocytes were differentiated on coverslips for 3 weeks and then fixed with
Fixation/Permeabilization Solution Kit (BD Cytofix/Cytoperm™). For immunostaining, the
fixed cells were blocked with 3% horse serum and incubated with primary antibody overnight at
4°C, followed by incubation with Alexa Fluor–conjugated antibody. The stained cells on
coverslips were washed, mounted, and then visualized using a Leica confocal SP5 microscope
(Leica Microscopes, Wetzlar, Germany). The images were processed with the Leica (LAS/AF)
suite (Wetzlar, Germany).
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Sucrose Gradient Fractionation
The membrane fraction was obtained by sucrose gradient fractionation as described previously
(H. Wang et al., 2004). In brief, Epidemdemal adipose tissue was washed with ice-cold PBS and
homogenized by polytron tissue grinder in 2ml 500 mM sodium carbonate (pH 11.0). Then the
lysate was sonicated for 3x40s, wait for 30s between two sonication operations. 2ml of each
sample was added to a tube for ultra-centrifugation, then add 2 ml of 90% sucrose in MBS
{25mM MES (2-(N-morpholino)ethanesulfonic acid) saline, 150mM NaCl, 2mM EDTA, pH
6.5} and mix by pipetting to reach final sucrose concentration of 45%. 4 ml of 35% sucrose (in
MBS, pH 6.5, with 250 mM sodium carbonate) were gently added, then gently add 4 ml of 5%
sucrose (in MBS, pH 6.5, with 250 mM sodium carbonate), centrifuge for 39K rpm for 17 hours
in an SW41 rotor (Beckman Coulter). Cell fractions were collected from top to bottom, 1 ml for
each fraction. Combine fractions 4&5, this is the caveolae enriched fraction. Eleven gradient
fractions of 1 ml were collected from the top to the bottom of the centrifuge tube. Fractions 4 and
5 were transferred and combined into a new ultra-centrifuge tube, 4 ml MBS was added with
250mM sodium carbonate, then centrifuge at 40K rpm in type 65 rotor for 1 hour. Supernatants
were removed, Pellets were resuspended in 250 ul MBS with 250 mM sodium carbonate, this
suspension is considered as the caveolae enriched membrane fraction. Equal volumes of each
fraction were analyzed by Western blot.
SDS-PAGE western blot analysis
Mature adipocytes were washed twice with ice-cold PBS and then solubilized in modified
radioimmunoprecipitation assay (RIPA) buffer containing 0.25% sodium deoxycholate, 1% NP40, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, 1 mM
NaF, aprotinin (10 g/ml), leupeptin (10 g/ml), 150 mM NaCl, and 50 mM Tris-HCl (pH 7.4).
63

Cell lysates were centrifuged at 14,000 rpm for 15 min; supernatants were collected. After
determining protein concentration by the Lowry method (Lowry, Rosebrough, Farr, & Randall,
1951), equal amounts of protein were loaded in each lane of freshly prepared SDS–
polyacrylamide gel electrophoresis gel. Separated proteins were transferred onto nitrocellulose
membranes, blocked with milk or bovine serum albumin solution in a mixture of TBST (trisbuffered saline and Tween 20) for 1 hour, and then incubated with the primary antibody in
blocking solution overnight. Membranes were washed three times with TBS-T, incubated with
secondary antibody in blocking solution for 1 hour, and washed again. Proteins were visualized
with enhanced chemiluminescence reagent (Thermo Fisher Scientific) and autoradiography
films. The intensity of bands was quantified with ImageJ 1.52a (Wayne Rasband, National
Institute of Health). The antibodies are listed in Table 3.
RT-qPCR
Total RNA was extracted from cell lysates using Trizol (Invitrogen #15596-018) and reversetranscribed into cDNA with the SuperScript III First-Strand Synthesis SuperMix (Thermo Fisher
# 18080400). The cDNA from each sample was then amplified in LightCycler 480 Instrument II
(Roche Life Science, Inc) through (LightCycler 480 SYBR Green I Master, Roche
#04887352001). All primers were synthesized by Integrated DNA Technologies, Inc. The primer
sequences are listed in Table 4-5.
RNA-Seq and Data Analysis
RNAseq analysis was performed by Novogene Co., LTD (California, USA). Briefly, mRNA was
fragmented with fragmentation buffer, and cDNAs were synthesized using them as templates.
After agarose gel electrophoresis, suitable fragments were selected for PCR amplification as
templates. During QC steps, Agilent BioAnalyzer 2100 and ABI StepOnePlus Real-Time PCR
64

System were used for quantification and qualification of the sample library. The library was
sequenced using HiSeq 2000 sequencer. Bioinformatic analysis was performed by deep analysis
of gene expression. Differential gene expression was established with a log10(padj) threshold of 1.2 using the DESeq2 package (Love, Huber, & Anders, 2014). The KEGG pathways were
specifically queried with a gmt file obtained at the KEGG website
(https://www.genome.jp/kegg/pathway.html.). Results were obtained with RStudio Version
1.3.1056
Statistical analysis
All data were presented as mean ±S.E.M. Statistical analysis was performed using the Student’s
t-test to compare two groups. When more than two groups were compared, one-way ANOVA
was performed before post-hoc comparison of individual groups using Dunnet’s multiple
comparison test. Significance was accepted at P < 0.05. Statistical analyses were performed
using GraphPad Prism version 6.01 for Windows, GraphPad Software. La Jolla, CA.
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Supplementary Materials
Primary Antibody
Source
NKA α1
Millipore #a6f
NKA α2
Millipore #07-674
α-Tubulin
Sigma #T5168
Cav1
Cell Signaling #3267
IRβ
Santa Cruz #6093
IRS1
Sigma I7153
GLUT4
Sigma #G4048
HIF-1α
Cell Signaling #36169S
Type I collagen
SounthernBiotech #1310-01
Secondary Antibody Source
HRP-conjugated
Santa Cruz #C1120
anti-mouse IgG
HRP-conjugated
R&D systems #HAF008
anti-rabbit IgG
Alexa Fluor 594
Invitrogen #A-11058
donkey anti-goat
Alexa Fluor 488 goat Invitrogen #A-32731
anti-rabbit
Table 3. List of antibodies
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Dilution
1000x
1000x
1000x
1000x
1000x
200x
1000x
1000x
200x
Dilution
1000x
1000x
200x
200x

Gene
SOX2

Sequences
Forward GCTACAGCATGATGCAGGACCA
Reverse TCTGCGAGCTGGTCATGGAGTT
SOX17
Forward TCATGGTGTGGGCTAAGGAC
Reverse CACGACTTGCCCAGCATCT
PDGFRA Forward GGGCACGCTCTTTACTCCAT
Reverse GCTCTGGGAAACTTCTCCTCC
PDGFRB Forward GGAGAGGGCAGTAAGGAGGA
Reverse ATGGTGTCCTTGCTGCTGAT
PPARγ
Forward GATACACTGTCTGCAAACATATCACAA
Reverse CCACGGAGCTGATCCCAA
FASN
Forward TCGTGGGCTACAGCATGGT
Reverse GCCCTCTGAAGTCGAAGAAGAA
ADIPOQ Forward TCTGCCTTCCGCAGTGTAGG
Reverse GGTGTGGCTTGGGGATACGA
FABP42 Forward GCTTTGCCACCAGGAAAGTG
Reverse ATGGACGCATTCCACCACCA
COL1A1 Forward GATTCCCTGGACCTAAAGGTGC
Reverse AGCCTCTCCATCTTTGCCAGCA
TGFB1
Forward CCCAGCATCTGCAAAGCTC
Reverse GTCAATGTACAGCTGCCGCA
FN1
Forward AATGTTGGTGAATCGCAGGT
Reverse GGAAAGTGTCCCTATCTCTGATACC
INR
Forward GCTGGTGTCTGAGCTTCAG
Reverse CTCGCACCCTTGAGAAGAACC
IRS1
Forward GTTTCCAGAAGCAGCCAGAG
Reverse ACTCTCTCCACCCAACGTGA
GLUT4
Forward GCCGGACGTTTGACCAGAT
Reverse TGGGTTTCACCTCCTGCTCTA
PFKM
Forward GGCTGTGGTTCGAGTTGGTA
Reverse CCAGGTGGCTTCCTTGATGT
ATP5A1 Forward AAGACACGCCCAGTTTCTTC
Reverse TTTGGGTTCATCTTTCATTGC
HIF1A
Forward CATAAAGTCTGCAACATGGAAGGT
Reverse ATTTGATGGGTGAGGAATGGGTT
IL6
Forward AGCCCTGAGAAAGGAGACATGTA
Reverse TCTGCCAGTGCCTCTTTGCT
CCL2
Forward CCCCAGTCACCTGCTGTTAT
Reverse TGGAATCCTGAACCCACTTC
HPRT1
Forward TGGACAGGACTGAACGTCTT
Reverse TCCAGCAGGTCAGCAAAGAA
Table 4. List of human primers sequences
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Gene

Sequences

Tnfa

Forward

GCCTCTTCTCATTCCTGCTTG

Reverse

CTGATGAGAGGGAGGCCATT

Forward

CTTCCATCCAGTTGCCTTCTTG

Reverse

AATTAAGCCTCCGACTTGTGAAG

Forward

CCTCAGGGTATTGCTGGACAAC

Reverse

CAGAAGGACCTTGTTTGCCAGG

Forward

GATGTCCGAACAGCTATTTACCA

Reverse

CCTTGCGACTTCAGCCACT

Forward

CGAAAGCATTTGCCAAGAAT

Reverse

AGTCGGCATCGTTTATGGTC

Il6

Col1a1

Fn1

18s

Table 5. List of mouse primers sequences
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Figure 15. Growth curve of mCBM mice.
A) mCBM heterozygous mice body weight-age growth curve, n=4. B) Organ weight of
epididymal/subcutaneous fat and C) daily food intake, n=5-6. Data reported as mean ±SE. *,
P < 0.05; **, P < 0.01 (Unpaired t-test with Welch's correction)
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Figure 16. In vitro iPSC-derived Adipogenesis model.
A) in vitro differentiation from human iPSC to adipocyte, MSC: mesenchymal stem cell. B)
mRNA levels of SOX2, PDGFRα and, PDGFRβ genes in iPSC-derived MSCs, n=3-6. Data
reported as mean ± SE. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (One-way ANOVA with Tukey
post hoc test)
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Figure 17. RNA sequencing and enrichment analysis in iPSC-derived adipocytes.
A) Comparison of RNA sequencing data of WT and mCBM adipocytes, n=3. Differentially
expressed genes were determined using DESeq2 and presented as fold change plotted against
adjusted p-value. B) Enriched KEGG pathways of decreased and increased genes. log10
(padj) < 1.2 considered nominally significant
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Figure 18. Basal Glycolysis on mCBM adipocytes.
A) Seahorse XF Cell Glycolysis Test in WT and mCBM iPSC-derived adipocytes, insulin was
removed from the medium 1 h before the test and was absent during the test. Respectively
Glucose, Oligomycin, and 2-DG were added to the cells after the basal ECAR was established
(as indicated by arrow). The data are normalized by protein amount as mpH/min/Norm. Unit. B)
Quantitation of basal glycolysis and glycolytic capacity of WT and mCBM iPSC-derived
adipocytes, calculated from data in Panel A, n=6. Data reported as mean ± SE. *, P < 0.05; **,
P < 0.01; ***, P < 0.001 (Unpaired t-test with Welch's correction)
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Figure 19. ECM remodeling in mCBM iPSCs.
A) Collagen deposition in WT, mCBM, and mCBM + exogenous mouse α1 (mCBM+Exα1)
human iPSCs, representative pictures from n=3 repeats. Scale bar = 500 𝜇m. B) mRNA levels of
TGFB1, COL1A1, and FN1 genes in WT, mCBM, and mCBM+Exα1 iPSCs measured by RTqPCR, n=4. C) NADPH/NADP ratio in iPSCs, n=4. The data were reported as mean ±SE. Data
reported as mean ±SE. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Unpaired t-test with Welch's
correction and one-way ANOVA with Tukey post hoc test)
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Figure 20. ECM remodeling in mCBM MSCs.
A) Collagen deposition in WT and mCBM MSCs, representative pictures from n=3 repeats.
Scale bar = 500 𝜇m. B) mRNA levels of COL1A1 and FN1 genes in WT and mCBM MSCs
measured by RT-qPCR, n=4. The data were reported as mean ±SE. Data reported as mean ±SE.
*, P < 0.05; **, P < 0.01; ***, P < 0.001 (Unpaired t-test with Welch's correction)
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Figure 21. TGF-β inhibitor (TGFi) SB431542 decreased ECM stiffness and hypoxia in
mCBM iPSCs.
A) WT and mCBM iPSCs were stained with type I collagen (red). Representative pictures are
selected from n=4 independent repeats. Scale bar = 500 𝜇m. B) mRNA expression for COL1A1,
FN1, and HIF1A genes in WT and mCBM iPSCs measured by RT-qPCR, n=4. C)
NADPH/NADP ratio in iPSCs measured by NADPH/NADP quantitation assay, n=4. Data
reported as mean ± SE. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (One-way ANOVA with Tukey
post hoc test)
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Figure 22. Exogenous mouse NKA α1 rescue of mCBM stem cells.
A) Vector map of the lentivirus expression vector containing a mouse Atp1a1 cDNA. B) mRNA
expression of the exogenous mouse Atp1a1 transgene (Ex α1) in iPSCs was measured by RTqPCR, n=4. The data were reported as mean ±SE. Data reported as mean ± SE. *, P < 0.05; **,
P < 0.01; ***, P < 0.001 (Unpaired t-test with Welch's correction)
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CHAPTER 3
DISCUSSION AND CONCLUSIONS
CBM is a tool to discriminate the ion transporting and signaling functions of NKA
isoforms.
NKA assembles signalosomes with other signaling partners. Series of studies have shown
that α1 NKA forms a signaling complex with Src, Cav1, EGFR, PI3R, PLC, and PKC (Cai et al.,
2008; Y. Chen et al., 2008; Haas et al., 2000; Z. Li & Xie, 2009; Liang et al., 2006; Mohammadi,
Kometiani, Xie, & Askari, 2001; H. Wang et al., 2004; Yuan et al., 2005). There are also reports
suggesting that α1 NKA is associated with other receptors, such as CD36, TLR4, angiotensin
receptor, and the TGF-β receptor (Y. Chen et al., 2017; Kennedy et al., 2013; Ketchem et al.,
2016; La et al., 2016). In addition to NKA α1 receptor interactions, the α2 NKA may form a
calcium signaling complex with NCX (Golovina, Song, James, Lingrel, & Blaustein, 2003). The
α3 and α4 isoform NKA can also mediate ouabain-induced signal transduction, but the
mechanism is not clear yet (Madan et al., 2017; Pierre et al., 2008). It has been difficult to
distinguish the signaling function and ion-pumping function of NKA using pharmacological
approaches or gene deletion. The conserved N-terminal CBM on NKA was first identified and
studied by Wang et al and Cai et al (Cai et al., 2008; H. Wang et al., 2004). The mCBM cell
shows disrupted NKA/Cav1/Src complex and blunted NKA-mediated signal transduction,
without an effect on the enzymatic function of NKA (Cai et al., 2008; X. Wang et al., 2020).
This mutant that maintains its pumping function but lacks signaling capacity provided an
excellent genetic model to further study the non-ion pumping properties of NKA. Interestingly,
unlike the α1 NKA specific Src binding sites, the CBM is also found in other sequences of NKA
α-isoforms (Lingrel, Van Huysse, O'Brien, Jewell-Motz, & Schultheis, 1994). This may imply
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that CBM is important for non-ion pumping properties of other NKA α-isoforms, such as α2
NKA crosstalk with NCX (Blaustein & Hamlyn, 2020), or other signaling partners.
Modulation of NKA α1 and α2 isoform expression during adipogenesis: a metabolic
signaling hypothesis.
The first study of mCBM in physiological processes by Wang et al. indicated the
essential role of NKA-Cav1 binding in embryonic development (X. Wang et al., 2020). This
provided the first line of genetic evidence that the non-ion pumping property of NKA is as
critical as its ion pumping function. The present study is the first to provide genetic evidence
supporting the role of the non-ion pumping property of α1 NKA in the regulation of
adipogenesis. This regulation is independent of a total change in allele NKA enzymatic capacity
in both iPSCs and adipocytes (Figure 10). However, in contrast to mCBM models in epithelial
cells, the mCBM adipocytes have reduced α1 NKA expression and increased expression of α2
NKA. The increase in α2 NKA may provide compensation for the change of α1, explaining why
the total enzymatic activity is constant. It should be noted that in the conditions of this study, we
cannot exclude a change of intracellular ion homeostasis of mCBM cells under physiological
conditions. Indeed, NKA-mediated signal transduction is critical for NKA internalization as well
as in the trafficking of other membrane ion transporters, such as NHE3 (J. Liu et al., 2004; J. Liu
et al., 2005; J. Liu & Shapiro, 2007; Yan et al., 2012). A redistribution of NKA is observed in
mCBM model cells, mCBM iPSCs, and mCBM adipose tissue (Figure 8) (Cai et al., 2008; X.
Wang et al., 2020). Hence, there may be an association between the signaling of NKA and the
modulation of cell membrane ion transport that is independent of the loss of total cellular Na/KATPase activity.
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Skeletal muscle and adipose tissue are the two major organs in whole-body energy
metabolism. Interestingly, the major NKA isoform in both of these organs is α2, which is
different from most other cells with ubiquitous α1 NKA as their major isoform. The isoform
switch from α1 to α2 happens during the adipogenesis and the myogenesis processes (Brodsky,
1990; Orlowski & Lingrel, 1988). During the same period, the cell gains insulin sensitivity
through increased expression of insulin signaling pathway components. During the development
of these two organs, the reason why α1 NKA needs to be replaced by α2 NKA has long been
unknown. An isoform-specific role of α1 Na/K-ATPase signaling is in the regulation of energy
metabolism was recently discovered in specifically manipulated cells and mice (Kutz et al.,
2021). In addition, we found that the disruption of α1 NKA signaling by mCBM impaired the
insulin signaling pathway and reduced the expression of the insulin signaling pathway
components (Figure 11). It is, therefore, possible that the NKA isoform-switch is associated with
an altered NKA-mediated signaling background (increase in basal levels of pERK, ROS…),
which is essential for the gain of insulin sensitivity during adipogenesis and myogenesis.
CBM-dependent scaffolding function during adipogenesis: role of Wnt/β-catenin and Srcmediated signal transduction during adipogenesis
Several studies have documented the specific NKA-Src binding sites in α1 NKA
(Banerjee et al., 2018; Lai et al., 2013; Z. Li et al., 2009; Yu et al., 2018). The NKA/Src/ROS
axis is the most studied downstream cascade of NKA-mediated signaling and is altered by the
mCBM mutation (Cai et al., 2008; X. Wang et al., 2020). Sodhi et al. have shown that inhibition
of NKA/Src/ROS signaling by pNaKtide attenuates adipogenesis, possibly due to the inhibition
of ROS signaling (Sodhi et al., 2015). Our data show that the ROS scavenger MitoTEMPO failed
to rescue the ECM fibrotic remodeling, but partially restored adipogenesis in mCBM iPSC-
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derived adipocytes (Figure 12). On the other hand, expression of an exogenous NKA α1 with
intact CBM or TGF-β inhibition did restore ECM, redox homeostasis, and lipid storage in
mCBM iPSCs (Figure 13 and 20). This suggests that the scaffolding function of NKA CBM
regulates redox homeostasis through an ECM/ROS axis during adipogenesis via a mechanism
that is, at least in part, independent from the NKA/Src/ROS mechanism. Similarly, the mCBMinduced defects in mouse embryogenesis observed in the recent study by Wang et al (X. Wang et
al., 2020) did not appear to be caused by the disruption of NKA/Src. Rather, Wang et al showed
that the disruption of NKA CBM-dependent control of Wnt/β-catenin played a critical role.
Consistent with a CBM-dependent mechanism that is not functionally mediated by Src, we have
obtained preliminary indications that pNaKtide treatment does not restore lipid storage in the
mCBM iPSC-derived adipocytes (unpublished observations).
Given the reported role of the NKA CBM/Wnt/β-catenin axis during embryonic
development, the possible impact of the Wnt signaling pathway (which is dominant in the
regulation of stem cell linage commitment) should also be considered in the context of the
present study. Indeed, the canonical Wnt signaling through the Wnt/β-catenin complex inhibits
adipogenesis in MSCs (Steger et al., 2010). Non-canonical Wnt ligands signal through β-cateninindependent pathways and can promote adipogenesis by inhibiting canonical Wnt (Seo et al.,
2009). The study by Wang et al. (X. Wang et al., 2020) showed that the disrupted Wnt/β-catenin
complex in mCBM cells leads to dramatically reduced canonical Wnt signaling pathway activity.
Hence, inhibition of canonical Wnt signaling upon CBM loss of function may have facilitated
cell linage commitment towards adipocyte. This is consistent with the increase in adipocyte
progenitor marker gene expression (PDGFRA and PDGFRB) that we observed in mCBM iPSC
(Figure 16). Importantly, beyond cell linage commitment, mesenchymal adipogenesis is
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independent of the Wnt/β-catenin signal pathway, and therefore unlikely to explain the defect in
lipid storage. On the other hand, the TGF-β signaling pathway regulates the balance of
fibroblasts and adipocytes in adipose tissue (Clouthier, Comerford, & Hammer, 1997; Song et
al., 2000; Sun et al., 2013; W. Wang et al., 2019). Increased fibrogenesis results in adipose tissue
remodeling, impaired adipogenesis, and adipose metabolic dysfunction, which is observed in
obesity development (Choe et al., 2016; Sun et al., 2013).
Taken together, these support a model whereby the loss of CBM in iPSC may disrupt
Wnt, TGF-β, and Src-dependent non-ion pumping NKA functions, which regulate different
phases of adipogenesis through downstream signaling pathways. Although this remains to be
explicitly tested, it supports the role of NKA as an important signal integrator in adipogenesis
and suggests a therapeutic potential.
α1 NKA as a novel target for developing therapeutics of obesity and related metabolic
disorders.
MAPK pathway and ROS have been reported to regulate energy metabolism in
adipocytes (Bost, Aouadi, Caron, & Binetruy, 2005; de Villiers et al., 2018). Liu, J et al. and
Yan, Y et al. have shown that increased ROS results in NKA oxidation, which inhibits its
activity and further promotes NKA degradation through endosomal/lysosomal proteolytic
pathways (J. Liu, Kennedy, Yan, & Shapiro, 2012; Yan et al., 2013). Decreases in functional
NKA α1 have been reported in adipose tissue biopsies from obese patients (Srikanthan, Feyh,
Visweshwar, Shapiro, & Sodhi, 2016), which may be due to the elevated oxidative stress caused
by excessive energy accumulation. Reduced functional NKA α1 may lead to dysregulation of the
NKA/Src/ROS amplification loop, further increasing oxidative stress, and ultimately facilitating
adipose dysfunction during obesity development. Consistent with this hypothesis, a series of
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studies from Sodhi, K have indicated the therapeutic effect of pNaKtide in obesity and related
complications (J. Liu et al., 2016; Sodhi et al., 2015; Sodhi et al., 2017). This validated α1 NKA,
and the downstream NKA/Src/ROS amplification loop, as a potential therapeutic target of
obesity. However, the downregulation of NKA during obesity development may also impair its
scaffolding function as a signal integrator, which is critical for adipose tissue remodeling and
metabolic function (Figure 14). During obesity development, adipose tissue fibrosis contributes
to chronic inflammation and metabolic dysfunction (Choe et al., 2016; Sun et al., 2013). Both
NKA/Src/ ROS and NKA/TGF-β/ECM/ROS axis may therefore be involved in this process.
Interestingly, the loss of progenitor cell stemness is another symptom in obese patients and
results in obesity-related complications in multiple organs (Rodrigues et al., 2015). The great
potential of MSC-based therapy in treating diabetic complications has been reported (Basmaeil et
al., 2020; Davey, Patil, O'Loughlin, & O'Brien, 2014; Khan et al., 2013). However, the adiposederived MSCs from obese patients show reduced stem cell function and differentiation ability
(Pachon-Pena et al., 2016). Treatment with ROS scavenger in obese stem cells improved
differentiation ability and therapeutic effect (Gu et al., 2015), suggesting that redox homeostasis
is key to restoring the function of obese stem cells.
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APPENDIX B
ABBREVIATIONS
2-DG - 2-Deoxy-D-glucose
2-NBDG - 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose
3D - three-dimensional
ADIPOQ - gene encodes adiponectin
ATP - adenosine triphosphate
Atp1a1 - gene encode Na/K-ATPase α1
ATPase - adenosine triphosphatase
bFGF - basic fibroblast growth factor
C/EBP - CCAAT enhancer binding protein
C57BL6 – a commonly used strain of inbred mice
CAV - gene encodes caveolin protein
Cav1 – caveolin-1
CBM – caveolin binding motif
CCL2 – gene encodes monocyte chemoattractant protein-1
CD36 - cluster of differentiation 36
cDNA - Complementary DNA
Cl - chlorine
CLS - Crown-like structures
COL1A1 – gene encodes collagen type I, α1
CRISPRCas9 - clustered regularly interspaced short palindromic repeats-CRISPR associated
protein 9
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CSD - caveolin scaffolding domain
C-terminus - carboxyl-terminus
CTS - Cardiotonic steroids
DMEM - Dulbecco's Modified Eagle Medium
DNA - deoxyribonucleic acid
EC50 - concentration of a drug that gives half-maximal response
ECAR - extracellular acidification rate
EchoMRI – a body composition analyzer
ECM - extracellular matrix
EDTA - ethylenediaminetetraacetic acid
EGFR - Epidermal Growth Factor Receptor
EGTA - ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
EM - Electron Microscopy
EO - endogenous ouabain
ERK - extracellular signal-regulated kinases
F - fluorine
F4/80 - EGF-like module-containing mucin-like hormone receptor-like 1
FACS - fluorescence-activated cell sorting
FASN - fatty acid synthase
FBS - fetal bovine serum
FCCP - carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone
FFA - free fatty acid
FITC - fluorescein isothiocyanate
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FN1 – gene encode fibronectin
FRET - Fluorescence Resonance Energy Transfer
GDP - gross domestic product
GFP - green fluorescent protein
GFR - glomerular filtration rate
GLUT4 - insulin-sensitive glucose transporter
GST - Glutathione-S-Transferase
GTP - guanosine triphosphate
H&E - Hematoxylin & Eosin
HEPES - 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HIF - hypoxia-inducible factor
HIF1A - gene encode HIF-1α
IACUC - Institutional Animal Care and Use Committee
IBMX - 3-Isobutyl-1-methylxanthine
IC50 - the concentration of an inhibitor where the response is reduced by half
IL-6 - interleukin 6
IP3R - inositol trisphosphate receptor
iPSC - induced pluripotent stem cell
IR - insulin receptor
IRS - insulin receptor substrate
ITP - immune thrombocytopenia
K - potassium
K+ - potassium ion
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KEGG - Kyoto Encyclopedia of Genes and Genomes
Kg - kilogram
LD - lipid droplet
LoxP - locus of X-over P1
MAPK - Mitogen-activated protein kinase
MBS - 25mM MES (2-(N-morpholino)ethanesulfonic acid
mCBM - F97A and F100A double mutant α1 Na/K-ATPase
MCP-1 - monocyte chemoattractant protein-1
MES - 2-(N-morpholino)ethanesulfonic acid
Mg - magnesium
Mg – magnesium
Mg2+ - Magnesium ion
mitoNeoD - A Mitochondria-Targeted Superoxide Probe
MitoTEMPO - a mitochondria-targeted superoxide dismutase
MMP - matrix metalloproteinases
mRNA - messenger RNA
MSC - mesenchymal stem cell
Na - sodium
Na/K-ATPase – sodium-potassium adenosine triphosphatase
Na+ - sodium ion
NADP - Nicotinamide adenine dinucleotide phosphate
NADPH - reduced form of NADP
NaN3 - sodium azide
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NCX - sodium-calcium exchanger
NHE3 - Sodium–hydrogen antiporter 3
NIH - National Institutes of Health
NKA - Na/K-ATPase
nM - nanomolar
N-terminus - NH2-terminus
OCR - oxygen consumption rate
PBS – phosphate-buffered saline
PDGFRA - gene encodes Platelet Derived Growth Factor Receptor Alpha
PDGFRB - gene encodes Platelet Derived Growth Factor Receptor Beta
PE - Phycoerythrin
PKFM – phosphofructokinase
PPARγ - proliferator-activated receptor-γ
RHO - The Rho family of GTPases
RHOGAP - RHO GTPase-activating proteins
RIPA - radioimmunoprecipitation assay
RNA - ribonucleic acid
RNA-seq - RNA sequencing
ROCK - RHO GTPase-RHO-associated kinase
ROS - reactive oxidative species
RT-qPCR - real-time polymerase chain reaction
SB431542 – a specific inhibitor of transforming growth factor-β superfamily type I
SDS - sodium dodecyl sulfate
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SE - standard error of the mean
sgDNA - guide RNA
Src - Proto-oncogene tyrosine-protein kinase Src
ssODN - single-stranded oligo donor
TBST - tris-buffered saline and Tween 20
TCA cycle - tricarboxylic acid cycle cycle
TGE motif - Threonine-Glycine-Glutamic motif
TGF - transforming growth factor
TLR4 - toll-like receptor 4
TNFα - tumor necrosis factor alpha
Tris - tris(hydroxymethyl)aminomethane
Trizol - a chemical solution used in the extraction of DNA and RNA
UTP - uridine triphosphate
Vmax - maximum turnover rate
WAT - white adipose tissue
Wnt - Wingless and Int-1
WT – wild type
μl - microlitter
μM - micromolar
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